losartan has been researched along with enalapril in 412 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 119 (28.88) | 18.2507 |
| 2000's | 208 (50.49) | 29.6817 |
| 2010's | 76 (18.45) | 24.3611 |
| 2020's | 9 (2.18) | 2.80 |
| Authors | Studies |
|---|---|
| Abbenante, G; Fairlie, DP; Leung, D | 1 |
| Funakoshi, J; Kakumoto, M; Okumura, K; Sakaeda, T; Takara, K; Tanigawara, Y | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Andricopulo, AD; Moda, TL; Montanari, CA | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Avdeef, A; Tam, KY | 1 |
| Barton, P; Luker, T; Wenlock, MC | 1 |
| Giacomini, KM; Huang, Y; Khuri, N; Kido, Y; Kosaka, A; Morrissey, KM; Sali, A; Wittwer, MB; Zhang, X; Zur, AA | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Altieri, P; De Mello, W | 1 |
| Brooks, DP; Edwards, RM; Gellai, M; Jugus, J; Ohlstein, EH; Ruffolo, RR; Sulpizio, A; Vickery, L; Weinstock, J | 1 |
| Hutchinson, FN; Webster, SK | 1 |
| Gavras, H; Gavras, I; Wang, YX; Wierzba, T | 1 |
| Blantz, RC; De Nicola, L; Gabbai, FB | 1 |
| Baker, KM; Beinlich, CJ; Morgan, HE; White, GJ | 1 |
| Higuchi, K; Inagami, T; Murakami, T; Nakajo, S | 1 |
| Lemmer, B; Schnecko, A; Witte, K | 1 |
| Kunert-Radek, J; Mucha, S; Pawlikowski, M; Pisarek, H; Sepien, H; Stawowy, A | 1 |
| Andoh, TF; Bennett, WM; Burdmann, EA; Coffman, TM; Connors, BA; Evan, A; Lindsley, J; Nast, CC | 1 |
| Cockcroft, JR; Goldberg, MR; Ritter, JM; Sciberras, DG | 2 |
| Mohabir, R; Strosberg, AM; Young, SD | 1 |
| Jover, B; Mimran, A; Nafrialdi, N | 1 |
| Araki, M; Imai, S; Kanda, T; Kobayashi, I; Murata, K; Suzuki, T | 1 |
| Gibson, KJ; Lumbers, ER; Stevenson, KM | 1 |
| Chang, P; Dickstein, K; Hall, C; Haunsø, S; Kjekshus, J; Remes, J; Willenheimer, R | 1 |
| Fitzgibbon, WR; Hutchison, FN; Imamura, A; Lacy, ER; Mackenzie, HS; Ploth, DW | 1 |
| Goldberg, A; Sweet, C | 1 |
| Canals, F; Cazaubon, C; Galindo, G; Lacour, C; Nisato, D; Segondy, D | 1 |
| Broten, TP; Chakravarty, PK; Gabel, RA; Greenlee, WJ; Kivlighn, SD; Naylor, EM; Patchett, AA; Schaffer, LW; Schorn, TW; Zingaro, GJ | 1 |
| Arcuri, KE; Goldberg, AI; Gradman, AH; Ikeda, LS; Nelson, EB; Snavely, DB; Sweet, CS | 1 |
| Birnbock, H; Doig, JK; Jones, CR; MacFadyen, RJ; Reid, JL | 1 |
| Gorodetsky, E; Weinstock, M | 1 |
| Bjornsson, TD; Bradstreet, TE; Goldberg, MR; Lewis, G; Lipert, S; McWilliams, EJ; Osborne, B; Pivadori, L; Tanaka, WK; Waldman, SA | 1 |
| Keeley, FW; Leenen, FH; Ruzicka, M | 1 |
| Brunner, HR; Burnier, M; Waeber, B | 1 |
| Eydelloth, RS; Hubert, MF; Keenan, KP; Molon-Noblot, S; Owen, RA; Siegl, PK | 1 |
| Leenen, FH; Ruzicka, M; Yuan, B | 1 |
| Morgan, T; Zhang, Y | 1 |
| Dupont, M; Jover, B; Mimran, A; Nafrialdi, N; Saladini, D | 1 |
| Holley, KE; Johnson, CM; Keith, DS; Torres, VE | 1 |
| Bertolino, F; Bessac, AM; John, GW; Jover, B; Maffre, M; Valentin, JP | 2 |
| Fukui, T; Horio, T; Kohno, M; Kurihara, N; Takeda, T; Yasunari, K; Yokokawa, K; Yoshiyama, M | 1 |
| Abeta, H; Asagami, T; Furukawa, L; Hino, T; Ishii, T; Kushiro, T; Otsuka, Y; Saito, F; Takahashi, A; Tomiyama, H | 1 |
| Jover, B; Mimran, A | 1 |
| Drexler, H; Holtz, J; Meybrunn, M; Riede, UN; Schieffer, B; Seitz, S; Wirger, A | 1 |
| de Jong, PE; de Zeeuw, D; Gansevoort, RT | 1 |
| Leenen, FH; Ruzicka, M | 1 |
| Divish, BJ; Opgenorth, TJ; Polakowski, JS; Pollock, DM | 1 |
| da Silva, SV; da Silva, VJ; Salgado, HC; Salgado, MC | 1 |
| Baba, N; Sakemi, T | 1 |
| Hostetter, TH; Rosenberg, ME; Smith, LJ | 1 |
| Blaine, EH; Huang, HC; Koepke, JP; Manning, RE; Olins, GM; Reitz, DB; Smits, GJ | 1 |
| Harmsen, E; Leenen, FH; Ruzicka, M; Yuan, B | 1 |
| Belz, GG; de Mey, C; Goldberg, MR; Li, Q; Schroeter, V; Wroblewski, JM | 1 |
| Bernard, R; Crain, EJ; McCall, DE; Quan, ML; Saye, JM; Smith, RD; Watson, CA; Wexler, RR; Wong, PC; Zaspel, AM | 1 |
| Cohen, LS; Friedman, EA | 1 |
| Armstrong, J; Brownfield, MS; Carnes, M; Rittenhouse, PA; Saydoff, JA; Van De Kar, LD | 1 |
| Velasquez, MT | 1 |
| De Mello, WC | 2 |
| Berman, R; Gazdick, LP; Goldberg, AI; Ruff, D; Sweet, CS | 1 |
| Fink, GD; Melaragno, MG | 1 |
| Greene, EL; Hostetter, TH; Kren, S | 1 |
| Hannedouche, TP; Lacour, B; Martinez, F; Natov, S; Schmitt, F | 1 |
| Abe, M; Hachisu, M; Hui, C; Konno, F; Nagura, J; Yamamoto, M; Yasuda, S | 1 |
| Bianchetti, MG; Donati-Genet, P | 1 |
| Bradstreet, TE; Byyny, RL; Merrill, DD; Sweet, CS | 1 |
| Demeilliers, B; Jover, B; Mimran, A | 2 |
| Chang, P; Dunlay, M; Grossman, W; Pitt, B; Timmermans, PB | 1 |
| Cline, C; Erhardt, L; Willenheimer, R | 1 |
| Hachisu, M; Hui, C; Konno, F; Nagura, J; Yamamoto, M; Yasuda, S | 1 |
| Miyazaki, M; Okunishi, H; Song, K; Takai, S; Tanaka, T | 1 |
| Assmann, KJ; de Jong, AS; Dijkman, HB; Koene, RA; Mentzel, S; van Son, JP; Wetzels, JF | 1 |
| Aukland, K; Iversen, BM; Wang, X | 1 |
| Jensen, HA; Omvik, P; Tikkanen, I | 1 |
| Cespedes, C; Dussaillant, GR; Gonzalez, H; Jalil, JE | 1 |
| Frohlich, ED; Hosoya, K; Nunez, E; Susic, D | 1 |
| Azizi, M; Chatellier, G; Guyene, TT; Ménard, J; Wargon, M | 1 |
| Forster, C; le Tran, Y | 1 |
| Arendshorst, WJ; Best, CF; Coffman, TM; Kim, HS; Oliverio, MI; Smithies, O | 1 |
| Eastwood, JB; MacGregor, GA; Missouris, CG; Ward, DE | 1 |
| Cohen, A; Erlich, Y; Rosenmann, E; Rosenthal, T | 1 |
| Bartunek, J; Lorell, BH; Thienelt, CD; Weinberg, EO | 1 |
| Dollerup, J; Jensen, HA; Mogensen, CE; Nielsen, B; Nielsen, S | 1 |
| Haneda, T; Kikuchi, K; Takeda, H | 1 |
| Chang, PI; Elkayam, U; Krauss, D; Lang, RM; Makris, L; McKelvie, RS; Ney, DE; Vaughan, DE; Yellen, LG | 1 |
| Chen, L; Fändriks, L; Holm, M; Johansson, B; Jönson, C; Pettersson, A | 1 |
| Hata, T; Makino, N; Otsuka, S; Sugano, M | 1 |
| Higaki, J; Kida, I; Matsumoto, K; Moriguchi, A; Morishita, R; Nakamura, T; Nakano, N; Ogihara, T; Tomita, N | 1 |
| Agostoni, P; Guazzi, M; Melzi, G | 1 |
| Frandsen, E; Ibsen, H; Petersen, JS; Worck, RH | 1 |
| Bruneval, P; Giudicelli, JF; Ménard, J; Richer, C | 1 |
| Alhenc-Gelas, F; Allegrini, J; Clozel, JP; Costerousse, O; Ménard, J | 1 |
| Brenner, BM; Mackenzie, HS; Ots, M; Rennke, HG; Troy, JL | 1 |
| Hertenberg, F; Smits, P; Vervoort, G; Wetzels, JF | 1 |
| Al-Bander, H; Hutchison, FN; Jones, H; Kaysen, GA; Webster, S | 1 |
| Alhenc Gelas, F; Huang, W; Osborne-Pellegrin, MJ | 1 |
| Aronovitz, MJ; Konstam, MA; Patten, RD; Salomon, RN; Smith, JJ; Taylor, K; Wight, J | 1 |
| Elliott, HL | 1 |
| Burnier, M; Goy, JJ; Minghelli, G; Seydoux, C | 1 |
| Onuigbo, M | 1 |
| Agabiti Rosei, E; Bettoni, G; Castellano, M; Guelfi, D; Muiesan, ML; Mulvany, MJ; Pasini, G; Piccoli, A; Porteri, E; Rizzoni, D | 1 |
| Hata, T; Makino, N; Niho, Y; Otsuka, S; Sawada, S; Sugano, M | 1 |
| Ambrosio, GB; Ceconi, C; Dalla Libera, L; Facchin, L; Leprotti, C; Serafini, F; Vescovo, G; Volterrani, M | 1 |
| Oparil, S | 1 |
| Border, WA; Noble, NA; Peters, H | 3 |
| Brown, MJ | 1 |
| Struthers, AD; Yee, KM | 1 |
| Laverty, R; Ledingham, JM | 1 |
| Mackay, FJ; Mann, RD; Pearce, GL | 1 |
| Kähönen, M; Kalliovalkama, J; Karjala, K; Mäkynen, H; Pörsti, I; Tolvanen, JP; Wu, X | 1 |
| Meleń-Mucha, G; Mucha, S; Pawlikowski, M | 1 |
| Berezin, AE; Vizir, VA | 4 |
| Acevedo, E; Ebensperger, R; Gálvez, A; González-Jara, F; Jalil, JE; Lavandero, S; Meléndez, J; Pérez-Montes, V; Sapag-Hagar, M | 1 |
| Flapan, AD; Goodfield, NE; Ludlam, CA; Newby, DE | 1 |
| Dargie, HJ; Davie, AP; McMurray, JJ | 1 |
| Dam, TV; deBlois, D; Hamet, P; Moreau, P; Tea, BS | 1 |
| Caldiz, CI; de Cingolani, GE | 1 |
| Cirigliano, MD; Nawarskas, JJ; Spinler, SA; Townsend, RR | 1 |
| Dukacz, SA; Kline, RL | 1 |
| Riegger, GA | 1 |
| Agostoni, P; Guazzi, M; Palermo, P; Pontone, G; Susini, F | 1 |
| Crkovská, J; Jirsa, M; Seráková, M; Stípek, S; Tesar, V; Vernerová, Z; Zima, T | 2 |
| Kähönen, M; Kalliovalkama, J; Magga, J; Pörsti, I; Romppanen, H; Ruskoaho, H; Tolvanen, JP; Vuolteenaho, O | 1 |
| Anderson, TJ; Charbonneau, F; Elstein, E; Haber, H | 1 |
| Andersen, S; Hansen, BV; Parving, HH; Rossing, P; Tarnow, L | 1 |
| Baldamus, CA; Marsen, TA; Pollok, M; Sukau, G | 1 |
| Eichler, HG; Frossard, M; Joukhadar, C; Müller, M; Schmid, R; Steffen, G | 1 |
| Anthuber, M; Büchner, M; Farkas, S; Frölich, D; Guba, M; Jauch, KW; Steinbauer, M | 1 |
| Doris, PA; Kähönen, M; Kalliovalkama, J; Pekki, A; Pörsti, I; Tolvanen, JP; Voipio, J; Wu, X; Ylitalo, P | 1 |
| Cho, SI; Jung, JS; Kim, BS; Kim, SJ; Kim, YK; Lim, YT; Woo, JS | 1 |
| deBlois, D; Der Sarkissian, S; Hamet, P; Tea, BS; Touyz, RM | 1 |
| Shand, BI | 1 |
| Andersen, S; Bos, H; De Jong, PE; De Zeeuw, D; Navis, G; Parving, HH; Rossing, P | 1 |
| Francisco-DoPrado, J; Gordo, WM; Moreno, H; Sampaio, RC; Tanus-Santos, JE | 1 |
| Bergström, G; Creutz, J; Göthberg, G; Karlström, G; Rudenstam, J | 1 |
| Bancale, E; Cacace, G; Cesano, G; Gigliola, G; Mengozzi, G; Mosso, R; Paradisi, L; Picciotto, G; Piccoli, G; Polloni, R; Roccatello, D; Rossi, D; Sena, LM | 1 |
| Meyer, TW; Olson, JL; Pagtalunan, ME | 1 |
| Avanza, AC; El Aouar, LM; Mill, JG | 1 |
| Benemio, G; Bruni, B; Porcellati, C; Reboldi, GP; Sacchi, N; Schillaci, G; Verdecchia, P | 1 |
| Bélanger, A; Godin, C; Hallé, JP; Lacourcière, Y; Marion, J; Ross, S; Wright, N | 1 |
| Brown, NJ; Vaughan, DE | 1 |
| Alexander, J; Azizi, M; Goldberg, A; Linhart, A; Ménard, J; Menten, J; Sweet, C | 1 |
| Duclos, J | 1 |
| Deutsch, P; Ianosi-Irimie, M | 1 |
| Crespo, MJ | 1 |
| Meyer, TW; Olson, JL; Sorooshian, M | 1 |
| Beevers, DG; Blann, AD; Edmunds, E; Li-Saw-Hee, FL; Lip, GY | 1 |
| Grabs, R; Olbrich, HG; Richter, H; Richter, M; Schramm, D; Skupin, M | 1 |
| Atabay, G; Celik, A; Ok, E; Töz, H; Unsal, A | 1 |
| Lynn, KL; Shand, BI | 1 |
| Chiang, GS; Lau, YK; Wong, KS; Woo, KT | 1 |
| Abe, A; Hosoya, T; Imasawa, T; Kuriyama, S; Tomonari, H | 1 |
| Basso, N; González Bosc, L; Kurnjek, ML; Müller, A | 1 |
| Blezer, EL; Joles, JA; Koomans, HA; Nicolay, K | 1 |
| Hanada, K; Ikeda, T; Ikemoto, F; Kawai, N; Nakao, M; Nishikibe, M; Ohta, H; Suzuki, J | 1 |
| Agostoni, P; Guazzi, M; Guazzi, MD | 1 |
| Calegari, V; do Prado, JF; Moreno, H; Paganelli, MO; Tanus-Santos, JE; Toledo, JC | 1 |
| Beevers, DG; Belgore, FM; Blann, AD; Li-Saw-Hee, FL; Lip, GY | 1 |
| Zieleniewski, W | 1 |
| Babu, A; Bhaduri, J; Kamath, S; Kumar, TR; Raju, BS; Rao, M; Shobha, JC | 1 |
| Esposito, G; Fox, JE; Hagaman, JR; Knowles, JW; Maeda, N; Mao, L; Rockman, HA; Smithies, O | 1 |
| Fagard, R; Lijnen, P; Pardaens, K; Thijs, L; Vinck, W | 1 |
| Abe, I; Kagiyama, S; Lin, Y; Matsumura, K; Tsuchihashi, T | 1 |
| Böhmig, G; Gruber, U; Köller, E; Mayer, G; Schmidt, A | 1 |
| Borhani, M; Curci, JA; Kelley, BJ; Liao, S; Miralles, M; Thompson, RW | 1 |
| Beevers, DG; Li-Saw-Hee, FL; Lip, GY | 1 |
| Kaikita, K; Kajiwara, I; Miyamoto, S; Nakamura, S; Ogawa, H; Sakamoto, T; Shimomura, H; Soejima, H; Suefuji, H; Takazoe, K; Yoshimura, M | 1 |
| Brenner, BM; Remuzzi, G; Ruggenenti, P | 1 |
| Andreucci, M; Balletta, MM; Esposito, R; Minutolo, R; Pisani, A; Russo, D; Signoriello, G | 1 |
| Owen, WF; Reddan, DN | 1 |
| Akkaya, V; Bozfakioğlu, S; Cine, N; Ismailoğlu, V; Sahin, S; Sever, MS; Türk, S; Yildiz, A | 1 |
| Basso, N; González Bosc, LV; Kurnjek, ML; Müller, A; Terragno, NA | 1 |
| Fagard, RH; Lijnen, PJ; Petrov, VV | 2 |
| Broulík, PD; Jirsa, M; Tesar, V; Zima, T | 1 |
| Asakura, M; Asanuma, H; Fukushima, T; Hori, M; Kitakaze, M; Kuzuya, T; Liao, Y; Minamino, T; Node, K; Ogai, A; Ogita, H; Sakata, Y; Sanada, S; Takashima, S; Yamada, J | 1 |
| Andrejak, M; Fournier, A; Mazouz, H; Monge, M; Oprisiu, R | 1 |
| Kamimoto, M; Kanazawa, M; Kawamura, T; Kohzuki, M; Kurosawa, H; Minami, N; Mori, N; Nagasaka, M; Saito, T; Wu, XM; Xu, HL; Yoshida, K | 1 |
| Kurtzman, NA | 1 |
| Açbay, O | 1 |
| Cerutti, S; Diolisi, A; Garganico, D; Gaudio, G; Grandi, AM; Grimoldi, P; Guasti, L; Mainardi, LT; Petrozzino, MR; Simoni, C; Venco, A; Zanotta, D | 1 |
| Achilli, F; Baglivo, J; Calchera, I; Capra, A; Failla, M; Gentile, G; Giannattasio, C; Grappiolo, A; Mancia, G; Meles, E; Sala, L; Vincenzi, A | 1 |
| Ellis, D | 1 |
| Davie, AP; Lowe, GD; McMurray, JJ; Rumley, A | 1 |
| Huang, X; Li, D; Lu, H; Wang, Z; Wei, H; Zhan, Y | 1 |
| Guo, Z; Lai, W; Li, J; Li, S; Liang, X; Liu, Y; Wu, P; Xiu, J; Zhang, Y; Zhong, S | 1 |
| Anders, RJ; Bakris, G; Fagan, T; Ram, V; Sica, D; Vaitkus, PT | 1 |
| Campbell, DJ; Mackie, FE; Meyer, TW | 1 |
| Baiano, A; Cardace, P; de Cristofaro, A; De Rosa, ML; Rossi, M | 1 |
| Gedik, O; Gürlek, A; Tütüncü, NB | 1 |
| Iwasaka, T; Masaki, H; Matsubara, H; Nishikawa, M; Nishiue, T; Shibasaki, Y | 1 |
| Diolisi, A; Garganico, D; Gaudio, G; Grandi, AM; Guasti, L; Simoni, C; Venco, A; Zanotta, D | 1 |
| Goh, J; Lam, CW; Li, PK; Lui, SF; Wang, AY; Yu, AW; Yu, LM | 1 |
| Achard, JM; Allard, J; Dalmay, F; Fournier, A; Mazouz, H; Pesteil, F | 1 |
| Chen, Q; Feng, L; Gordon, KL; Han, L; Johnson, RJ; Kanellis, J; Kang, DH; Lan, HY; Mazzali, M; Nakagawa, T; Watanabe, S; Xia, YY | 1 |
| Arora, P; Neki, NS | 1 |
| Guo, Z; Lai, W; Li, J; Li, S; Liu, Y; Wu, P; Xiu, JC; Xu, JP; Zhang, Y | 1 |
| Rapi, J | 1 |
| Alvarez, BV; Cingolani, HE; De Hurtado, MC; Ennis, IL | 1 |
| Andoh, TF; Bennett, WM; Isaac, J; Shihab, FS; Yi, H | 1 |
| Cocco, G; Jerie, P; Kohn, S | 1 |
| Beevers, DG; Jilma, B; Li-Saw-Hee, FL; Lip, GY; Wagner, OF | 1 |
| Barten, M; Gummert, J; Mohr, FW; Olbrich, HG; Richter, H; Richter, MH; Schramm, D; Skupin, M | 1 |
| Abdi, R; Dong, VM; Lee, CJ; Ntoso, KA | 1 |
| Anders, RJ; Calhoun, D; Mansoor, GA; Sica, DA; White, WB | 1 |
| Ishibashi, T; Maehara, K; Maruyama, Y; Noji, H; Ohkawara, H; Ohwada, T; Sakamoto, T; Shindo, J; Sugimoto, K; Yaoita, H | 1 |
| Iwasaka, T; Masaki, H; Matsubara, H; Nishiue, T; Shibasaki, Y | 1 |
| Furuse, M; Hamada, T; Hisatome, I; Igawa, O; Kinugasa, Y; Matsubara, K; Ohtahara, A; Shigemasa, C; Shimizu, H; Sonoyama, K; Tanaka, H; Yamamoto, T; Yamamoto, Y | 1 |
| Lester, MH; Resnick, LM | 1 |
| Basso, N; Boveris, A; Costa, LE; D'Amico, G; Kurnjek, ML; La-Padula, P; Lores-Arnaiz, S | 1 |
| Cho, BH; Kang, SK; Kim, W; Lee, S; Park, SK; Yu, HC | 1 |
| Maliszewska-Scislo, M; Rossi, NF; Scislo, TJ | 1 |
| Arinsoy, T; Derici, U; Donmez, G; Erbas, D; Hasanoglu, E; Onk, A; Sindel, S | 1 |
| Blankestijn, PJ; Klein, IH; Koomans, HA; Ligtenberg, G; Oey, PL | 1 |
| Aronovitz, MJ; Einstein, M; Konstam, MA; Lambert, M; Mendelsohn, ME; Pandian, NG; Patten, RD | 1 |
| Adhikari, PM; Bhat, P; Chowta, KN; Chowta, MN | 1 |
| Donnelly, SM; Drummond, KN; Gardiner, R; Klein, R; Kramer, MS; Mauer, M; Sinaiko, AR; Strand, TD; Suissa, S; Zinman, B | 1 |
| Giraldez, RR; Godoy, MF; Machado, MN; Maia, LN; Nicolau, JC; Ramires, JA; Vaz, VD; Vítola, J | 1 |
| Adams, MA; Bushfield, TL; Hale, TM; Woolard, J | 1 |
| Basso, N; de Cavanagh, EM; Ferder, L; Fraga, CG; Inserra, F; Piotrkowski, B; Stella, I | 1 |
| Ramanathan, M; Srinivasan, J; Suresh, B | 1 |
| Baggi, JM; Brandi, JM; Cordeiro, JA; de Godoy, MF; Joaquim, MR; Maia, LN; Nicolau, JC; Santos, M; Vítola, JV | 1 |
| Laifeng, S; Pei, Z; Xinglin, X; Yanwen, Z; Yi, T; Yingmao, R; Yishu, X; Yongli, L; Yuejin, Y; Zaijia, C | 1 |
| Hurley, RM; Macpherson, CF; Matsell, DG; White, CT | 1 |
| Arens, T; Dendorfer, A; Dominiak, P; Häuser, W; Qadri, F; Schwarz, EC | 1 |
| Fujimiya, T; Naito, K; Shiraishi, K; Yoshida, K | 1 |
| Agabiti-Rosei, E; Bianchi, R; Boari, GE; De Ciuceis, C; Guelfi, D; Paiardi, S; Porteri, E; Rezzani, R; Rizzoni, D; Rodella, L; Sleiman, I | 1 |
| Elías, MM; García, VM; Monasterolo, LA | 1 |
| Akalin, S; Akpinar, I; Deyneli, O; Haklar, G; Koç, M; Toprak, A; Velioğlu, A; Yavuz, D | 1 |
| Chapman, D; Dhalla, NS; Guo, X | 1 |
| Calvo, C; Campo, C; de la Sierra, A; Delgadillo, J; García-Puig, J; Gil-Extremera, B; Márquez, E; Oliván, J; Pontes, C; Roca Cusachs, A; Sanz de Castro, S | 1 |
| Azizi, M; Domergue, V; Giudicelli, JF; Gonzalez, MF; Ménard, J; Messadi, E; Richer-Giudicelli, C | 1 |
| Cruden, NL; Fox, KA; Newby, DE; Webb, DJ; Witherow, FN | 1 |
| Kemi, M; Matsumoto, H; Nishikibe, M; Ohta, H; Sasaki, M; Taguchi, K; Uehara, S | 1 |
| Cetinkaya, R; Odabas, AR; Selcuk, Y | 1 |
| Casarini, DE; Cavaglieri, Rde C; Dellê, H; Dominguez, WV; Graciano, ML; Malheiros, DM; Noronha, IL | 1 |
| Kaneko, K; Kaneko, M; Kanno, Y; Kotaki, S; Mimura, T; Suzuki, H; Takane, H | 1 |
| Brown, CA; Brown, SA; Cartier, LM; Dietrich, UM; Mathur, S; Munday, JS; Newell, MA; Sheldon, SE | 1 |
| Brull, DJ; Mattu, RK; Montgomery, HE; Morris, A; Needham, EW; Trevelyan, J | 1 |
| Dhalla, NS; Liu, X; Lukas, A; Machackova, J | 1 |
| Arneja, AS; Dhalla, NS; Ganguly, PK; Netticadan, T; Shah, KR | 1 |
| Dhalla, NS; Guo, X; Wang, J | 1 |
| Drucker, C; Graninger, M; Jilma, B; Minar, E; Reiter, R | 1 |
| Ito, E; Konno, Y; Nakahata, T; Suzuki, K; Tanaka, H; Tsugawa, K; Tsuruga, K; Waga, S | 1 |
| Dhalla, NS; Ren, B; Saini, HK; Sethi, R; Shao, Q; Takeda, N | 1 |
| Boner, G; Erman, A; Gafter, U; van Dijk, DJ; Veksler, S; Wittenberg, C | 1 |
| Dhalla, NS; Netticadan, T; Ren, B; Saini, HK; Shao, Q; Takeda, N | 1 |
| Edwards, RJ; Lambiase, PD; Marber, MS; Redwood, SR | 1 |
| Cruden, NL; Fox, KA; Ludlam, CA; Megson, I; Newby, DE; Tse, GH | 1 |
| Canepa, C; De Reyes, V; Dieguez, SM; Liern, M; Vallejos, G | 1 |
| Barat, A; Bosch, RJ; Esbrit, P; Gazapo, R; González, L; Izquierdo, A; Ortega, A; Rámila, D | 1 |
| Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Komuro, I; Kuwabara, Y | 1 |
| Lysiak-Szydłowska, W; Renke, M; Rutkowski, B; Rutkowski, P; Tylicki, L | 1 |
| Ahamed, KF; Jayadev, S; Kumaran, D; Ramanathan, M; Srinivasan, J; Suresh, B | 1 |
| Adani, GL; Baccarani, U; Boscutti, G; Bresadola, F; Gropuzzo, M; Mioni, G; Mioni, R; Montanaro, D; Risaliti, A; Sainz, M; Tulissi, P; Vallone, C | 1 |
| Chen, BM; Tao, LJ; Xiong, Y; Zhang, WR | 1 |
| Frohlich, ED; Matavelli, LC; Ono, H; Zhou, X | 1 |
| Iwai, K; Matsumoto, M; Morimoto, S | 1 |
| Berti, F; Bianchi, M; Bonomo, S; De Gennaro Colonna, V; Ferrario, P; Fioretti, S; Manfredi, B; Muller, EE; Rigamonti, A; Rossoni, G | 1 |
| Mattu, RK; Morris, A; Needham, EW; Trevelyan, J | 1 |
| Desfontis, JC; Gogny, M; Le Coz, O; Mallem, MY; Reculeau, O | 1 |
| Aihara, E; Hayashi, M; Kagawa, S; Takeuchi, K | 1 |
| Hanada, H; Higuma, T; Ishizaka, H; Maeda, N; Matsunaga, T; Mori, Y; Okumura, K; Onodera, H; Osanai, T; Sasaki, S; Tamura, Y; Yoshimachi, F | 1 |
| Eiam-Ong, S; Sueblinvong, T; Udom, J | 1 |
| Block, D; Bökenkamp, A; deJong, M; Ludwig, M; van Hagen, JM; van Wijk, JA | 1 |
| Gündüz, F; Kuru, O; Sentürk, UK | 1 |
| Adams, MA; Hale, TM; Hannan, JL; Heaton, JP; Smallegange, C | 1 |
| Hirooka, K; Isobe, F; Saito, M; Takada, M; Yasumura, Y | 1 |
| Weber, MA | 1 |
| Coleman, CI; Kalus, JS; White, CM | 1 |
| Chan, TM; Lai, KN; Li, FK; Tang, CS; Tang, S; Tse, KC | 1 |
| Iwasaka, T; Masaki, H; Matsubara, H; Matsumoto, N; Mori, Y; Nishikawa, M; Nishiue, T; Shibasaki, Y; Tamura, K | 1 |
| Chen, GQ; Chen, WL; Fang, NY; Jin, X; Liu, ZG; Shi, JZ; Wang, LS; Xia, L; Zhang, L; Zheng, Y | 1 |
| Devereux, RB; Krauser, DG | 1 |
| Hirata, A; Igarashi, M; Kadomoto, Y; Tominaga, M | 1 |
| Erhardt, LR; Höglund, P; Jönsson, BA; Juhlin, T; Ottosson, H | 1 |
| Bayraktutan, U; Campbell, M; Mahadevan, VS; McKeown, PP | 1 |
| Calabrò, R; Natale, F; Tedesco, MA | 1 |
| Donnelly, SM; Gardiner, R; Goodyer, P; Klein, R; Kramer, MS; Mauer, M; Moss, SE; Sinaiko, AR; Strand, T; Suissa, S; Zinman, B | 1 |
| Akalin, S; Aksoy, N; Cacina, H; Deyneli, O; Haklar, G; Taga, Y; Velioglu, A; Yavuz, D | 1 |
| Dhalla, NS; Liu, X; Sethi, R; Suzuki, H; Takeda, N; Tappia, PS | 1 |
| Barreto-Chaves, ML; Carneiro-Ramos, MS; Carvalho, MH; Ceravolo, GS; Fortes, ZB; Franco, MC; Nigro, D; Tostes, RC | 1 |
| Aghaeishahsavari, M; Argani, H; Ghorbanihaghjo, A; Noroozianavval, M; Rashtchizadeh, N; Veisi, P | 1 |
| Abitbol, C; Chandar, J; Montané, B; Zilleruelo, G | 1 |
| Binder, CJ; Bro, S; Nielsen, LB; Olgaard, K; Witztum, JL | 1 |
| da Cruz-Höfling, MA; da Silva, GH; Hyslop, S; Paffaro, VA; Pauli, JR; Saad, MJ; Salgado, I; Tarsitano, CA | 1 |
| Chiara Cavallini, M; Palmieri, V; Pini, R | 1 |
| Aghaeishahsavari, M; Argani, H; Ghorbanihaghjo, A; Hamzeiy, H; Jabbarpourbonyadi, M; Noroozianavval, M; Rashtchizadeh, N; Veisi, P | 1 |
| Bacal, F; Bocchi, EA; Chizzola, PR; Guimarães, GV; Issa, VS; Mangini, S; Moreira, SF; Pires, PV; Silva, CP; Souza, GE | 1 |
| Basso, N; Cini, R; Ferder, L; Inserra, F; Pietrelli, A; Terragno, NA | 1 |
| Inamdar, MN; Kumar, NP; Venkataraman, BV | 1 |
| Hoshikawa, S; Ito, S; Mori, K; Nakagawa, Y; Ozaki, H; Tani, J; Yoshida, K | 1 |
| Grabowski, EF; Ingelfinger, JR; Kushak, RI; Nestoridi, E; Tsukurov, O | 1 |
| Aghaeishahsavari, M; Argani, H; Babaei, H; Ghorbanihaghjo, A; Mesgari, M; Noroozianavval, M; Rashtchizadeh, N; Safa, J; Veisi, P | 1 |
| Buzuyeva, II; Filyushina, EE; Lazarev, VA; Markel', AL; Shmerling, MD; Yakobson, GS | 1 |
| Alexandrescu, S; Alpers, CE; Banas, M; Guo, S; Hudkins, KL; Iyoda, M; Kowalewska, J; Spencer, M; Wang, L; Wietecha, TA; Yi, K | 1 |
| Aoyagi, T; Nagai, R; Sonoda, M; Takenaka, K; Uno, K | 1 |
| Ahmadi, F; Dashti-Khavidaki, S; Faghihi, T; Khalili, H | 1 |
| Dhalla, NS; Elimban, V; Guo, X; Wang, J | 1 |
| Garzoni, LR; Henriques, Md; Lessa, MA; Levy, BI; Nascimento, AR; Rodrigues, CA; Sabino, B; Tibiriçá, E | 1 |
| Akasaka, T; Goto, M; Ikejima, H; Imanishi, T; Kobayashi, K; Kuroi, A; Mochizuki, S; Muragaki, Y; Yoshida, K | 1 |
| Altieri, PI; Crespo, MJ; Cruz, N; Escobales, N | 1 |
| Celiński, K; Czechowska, G; Korobowicz, E; Korolczuk, A; Madro, A; Prozorow-Król, B; Słomka, M | 1 |
| Kuroyanagi, A; Matsubara, H; Sakamoto, T; Shiraishi, H; Shirayama, T | 1 |
| Avanza, AC; Mansur, AP; Ramires, JA | 1 |
| Bocchi, EA; Carvalho, VO; Guimarães, GV | 1 |
| Devriendt, K; Proesmans, W; Van Dyck, M | 1 |
| Akbaş, H; Akkaya, B; Akman, S; Baysal, YE; Guven, AG; Kalay, S; Koyun, M | 1 |
| Cardoso, L; Evangelista, FS; Heimann, AS; Krieger, JE; Lacchini, S; Silva, GJ | 1 |
| Ajami, M; Firooz, A; Habibey, R; Hajiaboli, E; Pazoki-Toroudi, H | 1 |
| Chan, CM; Chiang, GS; Choong, HL; Foo, M; Fook-Chong, S; Lee, EJ; Lee, GS; Lim, CH; Tan, CC; Tan, HK; Tan, SH; Vathsala, A; Wong, SK; Woo, KT | 1 |
| Anazawa, T; Furuya, S; Hirayama, A; Iida, K; Kawamata, H; Kumabe, N; Matsumoto, M; Nagao, K; Onikura, M; Takahashi, H; Tani, S | 1 |
| Donnelly, S; Drummond, K; Gardiner, R; Goodyer, P; Gubler, MC; Klein, R; Mauer, M; Sinaiko, A; Strand, T; Suissa, S; Zinman, B | 1 |
| Basso, N; Ferder, L; Ferder, M; Inserra, F; Inserra, P; Paglia, N; Stella, I; Tenembaum, D; Userpater, M | 1 |
| Aoki, T; Funabiki, K; Gohda, T; Hagiwara, S; Horikoshi, S; Ishikawa, Y; Kaneko, S; Matsumoto, M; Murakoshi, M; Ohara, I; Tanimoto, M; Tomino, Y; Toyoda, H; Yamazaki, T | 1 |
| Corna, D; Gaspari, F; Haskell, L; Perico, N; Remuzzi, G; Rottoli, D; Zoja, C | 1 |
| Abe, M; Maruyama, T; Matsumoto, K; Okada, K | 1 |
| Ellrichmann, G; Gaupp, S; Gold, R; Kvakan, H; Lee, DH; Linker, RA; Manzel, A; Muller, DN; Rump, LC; Seubert, S; Stegbauer, J | 1 |
| Dhalla, NS; Elimban, V; Nijjar, MS; Xu, YJ; Zhang, M; Zhang, W | 1 |
| Hoque, R; Iqbal, M; Rahman, MS | 1 |
| Donnelly, SM; Gardiner, R; Goodyer, P; Klein, BE; Klein, R; Mauer, M; Myers, CE; Sinaiko, AR; Strand, T; Suissa, S; Zinman, B | 1 |
| Lee, KO; Liew, CF; Lim, P; Mukherjee, JJ; Tan, F | 1 |
| Artyushkova, EB; Belous, AS; Kochkarov, VI; Pashin, EN; Pokrovskaya, TG; Pokrovskii, MV; Zhavbert, ES | 1 |
| Naviglio, S; Pirozzi, F | 1 |
| Brockmann, M; Desch, M; Kurtz, A; Meyer, C; Milenkovic, VM; Schweda, F; Strauss, O; Todorov, V | 1 |
| Becari, C; Costa-Neto, CM; Garcia-Cairasco, N; Oliveira, JA; Pereira, MG; Salgado, MC | 1 |
| Furuse, Y; Hisatome, I; Ishida, K; Kaetsu, Y; Kato, M; Kinugasa, Y; Mizuta, E; Ogino, K; Shigemasa, C; Sugihara, S; Yanagihara, K | 1 |
| Barros, RT; dos Reis, LM; Graciolli, FG; Jorgetti, V; Moysés, RM; Titan, SM; Zatz, R | 1 |
| Buford, TW; Carter, CS; Chung, HY; Daniels, M; DuPree, J; Foster, TC; Giovaninni, S; Giovannini, S; Hubbard, GB; Ikeno, Y; Lee, S; Lees, H; Marzetti, E; Morgan, D; Seo, DO | 1 |
| Antzelevitch, C; Cordeiro, JM; Sicouri, S; Talarico, M | 1 |
| Dodson, P; Hobbs, FR; Sjølie, AK | 1 |
| Adesanoye, OA; Bamidele, TO; Ekor, M; Kale, OE; Odewabi, AO; Oritogun, KS | 1 |
| Carter, CS; Choi, YJ; Chung, HY; Heo, HS; Kim, JM; Leeuwenburgh, C; Mi Ha, Y; Seo, AY; Ye, BH; Yu, BP | 1 |
| Aziz, H; Bedja, D; Chen, Y; Dietz, HC; Doyle, JJ; Habashi, JP; Holm, TM; Judge, DP; Modiri, AN; Schoenhoff, F | 1 |
| Caletti, MG; Exeni, R; Grignoli, M; Missoni, M; Piantanida, JJ; Rasse, SM; Repetto, HA; Vezzani, C | 1 |
| Circelli, M; Cremonesi, G; Fogari, R; Mugellini, A | 1 |
| Ceci, L; Cheng, SH; Clayton, NP; Dinardo, CJ; Girgenrath, S; Hunter, RB; Keefe, KA; Leonard, JP; McCullough, JA; McVie-Wylie, A; Nelson, CA; Quigley, LA; Weber, WD; Wentworth, BM | 1 |
| Caramori, ML; Harindhanavudhi, T; Klein, R; Mauer, M; Sinaiko, A; Zinman, B | 1 |
| Carter, CS; Groban, L; Kassik, KA; Lin, MS; Lindsey, S; Machado, FS; Wang, H | 1 |
| Barros, RT; Dominguez, WV; M Vieira, J; Titan, SM; Zatz, R | 1 |
| Balakrishnan, A; Cassis, LA; Charnigo, R; Daugherty, A; Howatt, DA; Liau, G; Lu, H; Wu, C | 1 |
| Gopalakrishna, HN; Nair, V; Pai, MR; Pemminati, S; Shreyasi, C; Swati, B | 1 |
| Askar, M; Mazloum, H; Saeed, B | 1 |
| Dvorák, J; Kupec, J; Málek, F; Neuzil, P; Petrů, J; Sedivá, L; Táborský, M; Vondráková, D | 1 |
| Banoglu, ZN; Dengiz, GO; Kandemir, NO; Kurcer, Z; Mungan, G; Ozacmak, VH; Turkili, B | 1 |
| Berwanger, O; Mion Júnior, D; Ortega, KC; Silva, GV; Tsuji, RL | 1 |
| Futrakul, N; Futrakul, P | 1 |
| Cardoso, LM; Chianca, DA; da Silva, LG; de Menezes, RC; Fernandes, LG; Ferreira, AJ; Foureaux, G; Gomide, JM; Lima, MP; Miranda, PH; Pesquero, JL; Silva, FC | 1 |
| Gleim, GW; Lam, C; Massaad, R; Santoro, EP; Shahinfar, S; Sisk, CM; Webb, NJ; Wells, TG | 1 |
| Buzueva, II; Filyushina, EE; Lazarev, VA; Merkel, AL; Shmerling, MD; Yakobson, GS | 1 |
| Gleim, GW; Lam, C; Massaad, R; McCrary Sisk, C; Shahinfar, S; Webb, NJ; Wells, TG | 1 |
| Balestracci, A; Caletti, MG; Missoni, M; Vezzani, C | 1 |
| Czuczwar, SJ; Jakubus, T; Janowska, A; Lukawski, K; Raszewski, G | 1 |
| Hjemdahl, P; Kahan, T; Nussberger, J; Schwieler, JH; Wallén, NH | 1 |
| Cassis, LA; Daugherty, A; Gong, MC; Guo, Z; Liu, S; Pearson, KJ; Xie, Z | 1 |
| Boutros, PC; Cherney, DZ; Kennedy, CR; Lai, V; Miller, JA; Moineddin, R; Prokopec, SD; Reich, HN; Scholey, JW; Yang, S; Zinman, B | 1 |
| Barykina, IN; Chumachok, EV; Ledyaeva, AA; Mazina, G; Nedogoda, SV; Salasyuk, AS; Tsoma, VV | 1 |
| Feng, L; He, YM; Huo, DM; Liao, YH; Yang, ZH | 1 |
| Almenara, CC; Angeli, JK; Broseghini-Filho, GB; Faria, Tde O; Padilha, AS; Stefanon, I; Vassallo, DV; Vescovi, MV | 1 |
| Mauer, M; Robiner, WN; Strand, TD | 1 |
| Alexander, T; Baylis, C; Cunningham, MW; Fekete, A; Masilamani, SM; Sasser, JM; Shaw, S; West, CA | 1 |
| Baskın, E; Bayrakcı, US; Haberal, M; Moray, G; Sakallı, H | 1 |
| Aguila, MB; Batista, Tde M; Frantz, ED; Mandarim-de-Lacerda, CA; Penna-de-Carvalho, A | 1 |
| Kirichenko, N; Kwon, OS; Llinas, K; Powers, SK; Sakarya, Y; Scarpace, PJ; Smuder, AJ; Sollanek, KJ; Talbert, EE; Toklu, HZ; Tümer, N; Wiggs, MP | 1 |
| Jeffers, BW; Wang, JG; Yan, P | 1 |
| Chang, CH; Lai, MS; Lee, YC; Lin, JW; Lin, MS; Ruan, SY; Wu, LC | 1 |
| Becerril, C; Checa, M; Díaz-Piña, G; García de Alba, C; Montes, E; Ordoñez-Razo, R; Páramo, I; Ruiz, V; Vega, A | 1 |
| Hayashi, M; Iino, Y; Kawamura, T; Kuwahara, M; Nangaku, M; Uchida, S | 1 |
| Akpolat, M; Bayar, A; Gülle, K; Turan, A; Turan, İ; Turhan, E | 1 |
| Durán, A; Hernández-Fonseca, JP; Mosquera, J; Valero, N | 1 |
| Djuric, JM; Jankovic, SM; Jankovic, SV; Kostic, M; Stojadinovic, D; Stojadinovic, M; Stojic, I | 1 |
| Hall, SE; Kwon, OS; Morton, AB; Powers, SK; Smuder, AJ; Sollanek, KJ; Talbert, EE; Toklu, HZ; Tumer, N; Wiggs, MP | 1 |
| Hernández-Fonseca, JP; Mosquera, J; Pedreañez, A; Peña, C; Viera, N | 1 |
| Mugendi, GA; Mwangi, M; Ndwiga, S; Nyamu, DG; Nyamweya, NN; Okalebo, FA | 1 |
| Aboulkassim, T; Hamel, E; Imboden, H; Nicolakakis, N; Ongali, B; Tong, XK | 1 |
| Balogh, D; Banki, NF; Fekete, A; Fulop, N; Gellai, R; Hodrea, J; Hosszu, A; Koszegi, S; Lenart, L; Molnar, A; Szabo, AJ; Vannay, A; Ver, A; Wagner, L | 1 |
| Eng, DG; Gross, KW; Kaverina, NV; Kutz, JN; Lichtnekert, J; Pippin, JW; Shankland, SJ | 1 |
| Buchneva, NV; Kuzmin, OB; Landar, LN | 1 |
| de Araújo, JE; de Paula Facioli, T; de Souza, HC; Gastaldi, AC; Maida, KD | 1 |
| Bortolotto, LA; Consolim-Colombo, FM; Costa-Hong, V; Drager, LF; Fatureto-Borges, F; Giorgi, DAM; Jenner, R; Krieger, EM; Lopes, HF; Lorenzi-Filho, G; Marum, E; Teixeira, SH | 1 |
| Eng, DG; Freedman, BS; Gross, KW; Hamatani, H; Kaverina, NV; Pippin, JW; Shankland, SJ | 1 |
| Hamel, E; Imboden, H; Lecrux, C; Nicolakakis, N; Ongali, B; Tong, XK | 1 |
| Biojone, C; Casarotto, PC; Castrén, E; Diniz, CRAF; Fred, SM; Joca, SRL | 1 |
| Gupta, LK; Maharshi, V; Rehan, HS; Yadav, M | 1 |
| de Moura Leão, MF; de Oliveira, LFS; Duarte, JA; Machado, MM; Piccoli, JDCE; Sauzen, PD | 1 |
| Bispo-da-Silva, LB; Coelho Balbi, AP; de Morais, RB; do Couto Muniz, VP; Filho, SRF; Nakamura Hiraki, KR; Nunes Costa, E | 1 |
| Jensen, HE; Kvist, PH; Ougaard, ME; Petersen, EG; Thuen, ID | 1 |
| Arava, S; Gupta, YK; Joshi, D; Katyal, J | 1 |
| Diniz, LF; Gonçalves, RV; Lia Mazzeti, A; Mendonça, AAS; Novaes, RD; Souza-Silva, TG | 1 |
| Amin, DM; Arafa, MH; Atteia, HH; Samir, GM | 1 |
| Alvarez, M; Ardiles, L | 1 |
| Marin, GH | 1 |
| Danser, AHJ; Daugherty, A; Li, Z; Lu, HS; Mullick, AE; Wu, C; Ye, D | 1 |
| Bryant, CE; Hogg, RJ; Rajai, A; Webb, NJA | 1 |
| Agra, RM; Almengló, C; Álvarez, E; Couselo-Seijas, M; Eiras, S; García-Acuña, JM; González-Juanatey, JR; González-Peteiro, M; Varela-Román, A | 1 |
| Andrade-Sierra, J; Cerrillos-Gutiérrez, JI; Díaz-de la Cruz, EN; García-Sánchez, A; Miranda-Díaz, AG; Morales-Guillén, ML; Rojas-Campos, E | 1 |
| Kordeva, S; Lozev, I; Tchernev, G | 1 |
| Aguilar, BA; da Veiga Oliveira, AC; de Paula Facioli, T; de Souza, HCD; Ferreira, LD; Gastaldi, AC; Philbois, SV; Tank, J | 1 |
| Tchernev, G | 1 |
| Alaba, OA; Gumedze, F; Jones, ESW; Ntusi, NAB; Snyman, JR; Tsabedze, N; Vira, A | 1 |
18 review(s) available for losartan and enalapril
| Article | Year |
|---|---|
Protease inhibitors: current status and future prospects.
Topics: Animals; Aspartic Acid Endopeptidases; Cysteine Endopeptidases; Cysteine Proteinase Inhibitors; Humans; Metalloendopeptidases; Models, Molecular; Protease Inhibitors; Serine Endopeptidases; Serine Proteinase Inhibitors | 2000 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The advantages of angiotensin II antagonism.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Enalapril; Hemodynamics; Humans; Imidazoles; Kidney; Losartan; Renin-Angiotensin System; Tetrazoles | 1994 |
Angiotensin II receptor blockers. A new class of antihypertensive drugs.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzothiadiazines; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diuretics; Enalapril; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Multicenter Studies as Topic; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Sodium Chloride Symporter Inhibitors; Tetrazoles | 1996 |
Angiotensin II antagonists: efficacy, duration of action, comparison with other drugs.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Controlled Clinical Trials as Topic; Dose-Response Relationship, Drug; Enalapril; Humans; Hypertension; Losartan; Treatment Outcome | 1998 |
Irbesartan treatment in hypertension.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Biphenyl Compounds; Enalapril; Humans; Hypertension; Irbesartan; Losartan; Renin-Angiotensin System; Tetrazoles | 1998 |
[ACE inhibitors or AT1 receptor antagonists?].
Topics: Age Factors; Aged; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Captopril; Clinical Trials as Topic; Death, Sudden, Cardiac; Enalapril; Heart Failure; Humans; Losartan; Prodrugs; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Tetrazoles; Time Factors | 1999 |
[Irbesartan: a new possibility in the treatment of hypertension].
Topics: Acrylates; Angiotensin Receptor Antagonists; Antihypertensive Agents; Atenolol; Benzimidazoles; Benzoates; Biological Availability; Biphenyl Compounds; Controlled Clinical Trials as Topic; Drug Administration Schedule; Enalapril; Half-Life; Humans; Hypertension; Imidazoles; Irbesartan; Losartan; Telmisartan; Tetrazoles; Thiophenes; Valine; Valsartan | 2002 |
[Ace inhibitors and angiotensin II receptor antagonists for therapy of chronic heart failure].
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Enalapril; Heart Failure; Humans; Indoles; Lisinopril; Losartan; Renin-Angiotensin System; Tetrazoles; Valine; Valsartan | 2005 |
[Treatment of hypertension in elderly patients with coronary heart disease].
Topics: Adrenergic beta-Antagonists; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Coronary Disease; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Losartan; Randomized Controlled Trials as Topic; Treatment Outcome | 2005 |
The role of the new beta-blockers in treating cardiovascular disease.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Antihypertensive Agents; Atenolol; Benzopyrans; Cardiovascular Diseases; Clinical Trials as Topic; Enalapril; Ethanolamines; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Labetalol; Losartan; Male; Metoprolol; Middle Aged; Nebivolol; Nifedipine; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Sympathomimetics | 2005 |
The impact of suppressing the renin-angiotensin system on atrial fibrillation.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibrillation; Combined Modality Therapy; Electric Countershock; Enalapril; Humans; Indoles; Losartan; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Secondary Prevention; Tetrazoles; Valine; Valsartan | 2006 |
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan | 2006 |
Does renin-angiotensin system blockade have a role in preventing diabetic retinopathy? A clinical review.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Enalapril; Humans; Losartan; Renin-Angiotensin System; Tetrazoles | 2011 |
Combination delapril/manidipine as antihypertensive therapy in high-risk patients.
Topics: Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Clinical Trials as Topic; Diabetes Complications; Dihydropyridines; Drug Combinations; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Indans; Irbesartan; Losartan; Nitrobenzenes; Obesity; Olmesartan Medoxomil; Piperazines; Ramipril; Tetrazoles; Valine; Valsartan | 2011 |
Enalapril versus losartan for adults with chronic kidney disease: a systematic review and meta-analysis.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Pressure; Chi-Square Distribution; Cough; Creatinine; Enalapril; Female; Humans; Kidney; Losartan; Male; Middle Aged; Odds Ratio; Renal Insufficiency, Chronic; Renin-Angiotensin System; Risk Factors; Treatment Outcome; Uric Acid | 2013 |
Effects of amlodipine and other classes of antihypertensive drugs on long-term blood pressure variability: evidence from randomized controlled trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiovascular Diseases; Chlorthalidone; Enalapril; Humans; Hypertension; Lisinopril; Losartan; Randomized Controlled Trials as Topic | 2014 |
Could angiotensin-modulating drugs be relevant for the treatment of Trypanosoma cruzi infection? A systematic review of preclinical and clinical evidence.
Topics: Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Captopril; CD8-Positive T-Lymphocytes; Chagas Cardiomyopathy; Chagas Disease; Clinical Studies as Topic; Cytokines; Drug Evaluation, Preclinical; Enalapril; Humans; Losartan; Mice; Trypanosoma cruzi | 2019 |
117 trial(s) available for losartan and enalapril
| Article | Year |
|---|---|
Comparison of angiotensin-converting enzyme inhibition with angiotensin II receptor antagonism in the human forearm.
Topics: Adult; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Bradykinin; Double-Blind Method; Drug Interactions; Enalapril; Forearm; Heart Rate; Humans; Imidazoles; Losartan; Male; Regional Blood Flow; Tetrazoles; Vascular Resistance; Vasoconstriction; Vasodilation | 1993 |
Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Biphenyl Compounds; Chronic Disease; Confounding Factors, Epidemiologic; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Enalapril; Exercise Test; Feasibility Studies; Female; Heart Failure; Humans; Imidazoles; Losartan; Male; Middle Aged; Severity of Illness Index; Tetrazoles; Treatment Outcome | 1995 |
Efficacy and safety of losartan.
Topics: Antihypertensive Agents; Atenolol; Biphenyl Compounds; Blood Pressure Monitoring, Ambulatory; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Enalapril; Felodipine; Humans; Hypertension; Imidazoles; Losartan; Placebos; Tetrazoles | 1995 |
A randomized, placebo-controlled, double-blind, parallel study of various doses of losartan potassium compared with enalapril maleate in patients with essential hypertension.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Tetrazoles | 1995 |
Responses to an orally active renin inhibitor, remikiren (Ro 42-5892), after controlled salt depletion in humans.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Electrolytes; Enalapril; Heart Rate; Hormones; Humans; Imidazoles; Losartan; Male; Renin; Sodium; Tetrazoles | 1995 |
Biochemical effects of losartan, a nonpeptide angiotensin II receptor antagonist, on the renin-angiotensin-aldosterone system in hypertensive patients.
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Norepinephrine; Renin; Renin-Angiotensin System; Tetrazoles | 1995 |
Is the antiproteinuric effect of ACE inhibition mediated by interference in the renin-angiotensin system?
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Pressure; Enalapril; Female; Humans; Hypertension; Imidazoles; Kidney; Losartan; Male; Middle Aged; Proteinuria; Renal Circulation; Renin-Angiotensin System; Tetrazoles | 1994 |
Clinical pharmacology of angiotensin and bradykinin in human forearm vasculature.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Biphenyl Compounds; Blood Vessels; Bradykinin; Enalapril; Forearm; Humans; Imidazoles; Losartan; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Tetrazoles | 1993 |
Differential effects of oral losartan and enalapril on local venous and systemic pressor responses to angiotensin I and II in healthy men.
Topics: Administration, Oral; Adult; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Double-Blind Method; Enalapril; Hand; Humans; Imidazoles; Losartan; Male; Reference Values; Renin; Tetrazoles; Vasoconstriction; Veins | 1996 |
Comparative effects of combination drug therapy regimens commencing with either losartan potassium, an angiotensin II receptor antagonist, or enalapril maleate for the treatment of severe hypertension.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Heart Rate; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Tetrazoles | 1996 |
Renal effects of angiotensin I-receptor blockade and angiotensin convertase inhibition in man.
Topics: Adult; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Drug Synergism; Enalapril; Humans; Imidazoles; Kidney; Losartan; Male; Peptidyl-Dipeptidase A; Regional Blood Flow; Renal Circulation; Renin; Tetrazoles | 1996 |
An inpatient trial of the safety and efficacy of losartan compared with placebo and enalapril in patients with essential hypertension.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Inpatients; Losartan; Male; Middle Aged; Placebos; Single-Blind Method; Tetrazoles | 1996 |
Rationale, background, and design of the randomized angiotensin receptor antagonist--angiotensin-converting enzyme inhibitor study (RAAS).
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Double-Blind Method; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Imidazoles; Losartan; Pilot Projects; Randomized Controlled Trials as Topic; Research Design; Tetrazoles; Titrimetry; Ventricular Dysfunction, Left | 1996 |
Comparison of the angiotensin II antagonist losartan with the angiotensin converting enzyme inhibitor enalapril in patients with essential hypertension.
Topics: Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Blood Pressure; Cough; Diastole; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Systole; Tetrazoles | 1995 |
Additive effects of losartan and enalapril on blood pressure and plasma active renin.
Topics: Adolescent; Adult; Aldosterone; Angiotensin I; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Cross-Over Studies; Dose-Response Relationship, Drug; Double-Blind Method; Enalapril; Heart Rate; Humans; Hydrocortisone; Imidazoles; Losartan; Male; Peptidyl-Dipeptidase A; Renin; Tetrazoles; Time Factors | 1997 |
Losartan reduces albuminuria in patients with essential hypertension. An enalapril controlled 3 months study.
Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Male; Middle Aged; Tetrazoles | 1997 |
Comparative effects of losartan and enalapril on exercise capacity and clinical status in patients with heart failure. The Losartan Pilot Exercise Study Investigators.
Topics: Activities of Daily Living; Administration, Oral; Adult; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Double-Blind Method; Enalapril; Exercise Test; Exercise Tolerance; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Stroke Volume | 1997 |
Comparison of changes in respiratory function and exercise oxygen uptake with losartan versus enalapril in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Cardiomyopathy, Dilated; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Enalapril; Exercise Test; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Pulmonary Diffusing Capacity; Pulmonary Ventilation; Respiratory Mechanics | 1997 |
Influence of angiotensin converting enzyme inhibition and angiotensin II type 1 receptor antagonism on renal sodium and water handling and albuminuria during infusion of atrial natriuretic factor into healthy volunteers.
Topics: Adult; Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Natriuretic Factor; Blood Pressure; Diuresis; Double-Blind Method; Enalapril; Humans; Infusions, Intravenous; Losartan; Natriuresis; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation | 1998 |
Uricosuric effect of the angiotensin II receptor antagonist losartan in heart transplant recipients.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Cross-Over Studies; Double-Blind Method; Enalapril; Heart Transplantation; Humans; Losartan; Male; Middle Aged; Uric Acid; Uricosuric Agents | 1998 |
Improved exercise tolerance after losartan and enalapril in heart failure: correlation with changes in skeletal muscle myosin heavy chain composition.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Exercise Tolerance; Heart Failure; Humans; Losartan; Male; Middle Aged; Muscle, Skeletal; Myosin Heavy Chains | 1998 |
Endogenous angiotensin II and baroreceptor dysfunction: a comparative study of losartan and enalapril in man.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Baroreflex; Blood Pressure; Double-Blind Method; Enalapril; Heart Rate; Humans; Losartan; Male; Pressoreceptors; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Renin-Angiotensin System | 1998 |
Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Natriuretic Factor; Blood Pressure; Cardiomyopathy, Dilated; Cross-Over Studies; Enalapril; Female; Fibrinolysis; Heart Failure; Heart Rate; Hemodynamics; Humans; Losartan; Male; Myocardial Ischemia; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Single-Blind Method; Tissue Plasminogen Activator; Ventricular Dysfunction, Left | 1999 |
Role of bradykinin in the vasodilator effects of losartan and enalapril in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Cross-Over Studies; Double-Blind Method; Drug Interactions; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Vasodilator Agents | 1999 |
Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Aspirin; Blood Pressure; Cross-Over Studies; Cyclooxygenase Inhibitors; Double-Blind Method; Drug Interactions; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Patient Compliance; Thromboxane B2 | 1999 |
Synergistic efficacy of enalapril and losartan on exercise performance and oxygen consumption at peak exercise in congestive heart failure.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Double-Blind Method; Drug Synergism; Enalapril; Exercise Test; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Oxygen Consumption; Treatment Outcome | 1999 |
Comparative study of ACE-inhibition, angiotensin II antagonism, and calcium channel blockade on flow-mediated vasodilation in patients with coronary disease (BANFF study)
Topics: Aged; Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Calcium Channel Blockers; Coronary Circulation; Coronary Disease; Drug Therapy, Combination; Enalapril; Endothelium, Vascular; Female; Humans; Isoquinolines; Losartan; Male; Middle Aged; Quinapril; Tetrahydroisoquinolines; Vasodilation | 2000 |
Renoprotective effects of angiotensin II receptor blockade in type 1 diabetic patients with diabetic nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Enalapril; Female; Glomerular Filtration Rate; Humans; Hypertension, Renal; Losartan; Male; Proteinuria; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2000 |
Haemorheological effects of losartan and enalapril in patients with renal parenchymal disease and hypertension.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Circulation; Blood Viscosity; Enalapril; Erythrocyte Deformability; Female; Fibrinogen; Humans; Hypertension; Kidney Diseases; Losartan; Male; Middle Aged; Prospective Studies | 2000 |
Effects of angiotensin II blockade on nitric oxide blood levels in IgA nephropathy.
Topics: Adult; Aged; Albuminuria; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Glomerulonephritis, IGA; Hemoglobins; Humans; Isosorbide Dinitrate; Losartan; Male; Middle Aged; Nitric Oxide; Nitric Oxide Donors; Reference Values; Renal Circulation | 2000 |
Reduction in left ventricular hypertrophy in hypertensive patients treated with enalapril, losartan or the combination of enalapril and losartan.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Renin-Angiotensin System; Ventricular Function, Left | 2000 |
Long-term effects of losartan and enalapril, alone or with a diuretic, on ambulatory blood pressure and cardiac performance in hypertension: a case-control study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carrier Proteins; Case-Control Studies; Diuretics; Drug Synergism; Drug Therapy, Combination; Echocardiography; Enalapril; Female; Follow-Up Studies; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Organic Anion Transporters; Organic Cation Transport Proteins; Sodium Chloride Symporter Inhibitors; Uric Acid; Ventricular Function, Left | 2000 |
Long-term comparison of losartan and enalapril on kidney function in hypertensive type 2 diabetics with early nephropathy.
Topics: Aged; Albuminuria; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension, Renal; Kidney; Losartan; Male; Middle Aged; Prospective Studies; Sodium Chloride Symporter Inhibitors; Uric Acid | 2000 |
Pilot study of combined blockade of the renin-angiotensin system in essential hypertensive patients.
Topics: Adolescent; Adult; Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Pilot Projects; Renin-Angiotensin System; Treatment Outcome | 2000 |
[Prospects of endothelial dysfunction reversion in patients with congestive heart failure].
Topics: Angina Pectoris; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Brachial Artery; Enalapril; Endothelium, Vascular; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Stroke Volume; Ultrasonography, Doppler, Pulsed; Vasodilation | 2000 |
Comparison of enalapril and losartan in the treatment of posttransplant erythrocytosis.
Topics: Antihypertensive Agents; Enalapril; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Losartan; Male; Polycythemia; Postoperative Complications | 2000 |
A comparative study of losartan and enalapril on erythropoiesis and renal function in hypertensive patients with renal parenchymal disease.
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Erythropoiesis; Female; Humans; Hypertension; Kidney; Kidney Diseases; Losartan; Male; Middle Aged | 2000 |
ACEI/ATRA therapy decreases proteinuria by improving glomerular permselectivity in IgA nephritis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Creatinine; Enalapril; Female; Glomerulonephritis, IGA; Humans; Kidney; Losartan; Male; Middle Aged; Proteinuria; Treatment Outcome | 2000 |
Evaluation of efficacy and safety of losartan potassium in the treatment of mild to moderate hypertension as compared to enalapril maleate.
Topics: Adult; Double-Blind Method; Enalapril; Female; Humans; Hypertension; India; Losartan; Male; Middle Aged; Treatment Outcome | 2000 |
A randomised, placebo-controlled, double-blind, crossover study of losartan and enalapril in patients with essential hypertension.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Time | 2001 |
The effect of ACE inhibitor and angiotensin II receptor antagonist therapy on serum uric acid levels and potassium homeostasis in hypertensive renal transplant recipients treated with CsA.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Cyclosporine; Enalapril; Female; Homeostasis; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Losartan; Male; Middle Aged; Potassium; Prospective Studies; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Uric Acid | 2001 |
Effect of antihypertensive therapy using enalapril or losartan on haemostatic markers in essential hypertension: a pilot prospective randomised double-blind parallel group trial.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Cross-Sectional Studies; Double-Blind Method; Enalapril; Female; Fibrinogen; Hemostasis; Humans; Hypertension; Losartan; Male; Middle Aged; P-Selectin; Pilot Projects; Plasminogen Inactivators; Prospective Studies; Statistics, Nonparametric; von Willebrand Factor | 2001 |
Comparison of effects of losartan versus enalapril on fibrinolysis and coagulation in patients with acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Angioplasty, Balloon, Coronary; Blood Coagulation Factors; Double-Blind Method; Enalapril; Female; Fibrinolysis; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Plasminogen Inactivators; Thrombolytic Therapy; Thromboplastin; Tissue Plasminogen Activator | 2001 |
Coadministration of losartan and enalapril exerts additive antiproteinuric effect in IgA nephropathy.
Topics: Adult; Aldosterone; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Cohort Studies; Dose-Response Relationship, Drug; Drug Synergism; Drug Therapy, Combination; Enalapril; Female; Glomerulonephritis, IGA; Humans; Linear Models; Losartan; Male; Proteinuria; Renin; Treatment Outcome | 2001 |
Comparison of the effects of enalapril and losartan on posttransplantation erythrocytosis in renal transplant recipients: prospective randomized study.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Genotype; Hemoglobins; Humans; Kidney Transplantation; Losartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Polycythemia; Prospective Studies | 2001 |
Long-term treatment with enalapril or losartan does not show antiproliferative effects in peripheral blood mononuclear cells.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Cell Division; Cross-Over Studies; Double-Blind Method; Enalapril; Humans; Hypertension; Leucine; Losartan; Male; Middle Aged; T-Lymphocytes; Thymidine; Time Factors; Uridine | 2001 |
T-lymphocyte and plasma angiotensin-converting enzyme activity during enalapril and losartan administration in humans.
Topics: Administration, Oral; Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Double-Blind Method; Enalapril; Humans; Hypertension; Losartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Statistics, Nonparametric; T-Lymphocytes, Cytotoxic | 2001 |
Effects of low-dose losartan treatment on persistent microalbuminuria in normotensive type 1 diabetic subjects.
Topics: Adult; Albuminuria; Antihypertensive Agents; Blood Pressure; Cross-Over Studies; Diabetes Mellitus, Type 1; Dose-Response Relationship, Drug; Enalapril; Humans; Losartan; Reference Values; Single-Blind Method | 2001 |
Autonomic function and baroreflex sensitivity during angiotensin-converting enzyme inhibition or angiotensin II AT-1 receptor blockade in essential hypertensive patients.
Topics: Adult; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Autonomic Nervous System; Baroreflex; Cross-Over Studies; Enalapril; Heart Rate; Humans; Hypertension; Losartan; Male; Middle Aged; Statistics, Nonparametric | 2001 |
Radial artery flow-mediated dilatation in heart failure patients: effects of pharmacological and nonpharmacological treatment.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Blood Flow Velocity; Drug Administration Schedule; Echocardiography, Doppler; Enalapril; Exercise Test; Exercise Therapy; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Radial Artery; Vasodilation | 2001 |
Effect of chronic angiotensin II type I receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic variables in patients with heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Fibrinolysis; Heart Failure; Humans; Losartan; Plasminogen Activator Inhibitor 1; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Ventricular Dysfunction, Left | 2001 |
A comparative trial of controlled-onset, extended-release verapamil, enalapril, and losartan on blood pressure and heart rate changes.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Enalapril; Female; Heart Rate; Humans; Hypertension; Losartan; Male; Middle Aged; Vasodilator Agents; Verapamil | 2002 |
Comparative effects of chronic ACE inhibition and AT1 receptor blocked losartan on cardiac hypertrophy and renal function in hypertensive patients.
Topics: Analysis of Variance; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Echocardiography; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney; Kidney Function Tests; Long-Term Care; Losartan; Male; Middle Aged; Probability; Radionuclide Imaging; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Treatment Outcome | 2002 |
Efficacy of ACE inhibitors and ATII receptor blockers in patients with microalbuminuria: a prospective study.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Diabetes Mellitus, Type 2; Enalapril; Glycated Hemoglobin; Humans; Losartan; Middle Aged; Prospective Studies | 2001 |
Angiotensin II type 1 receptor antagonist, losartan, causes regression of left ventricular hypertrophy in end-stage renal disease.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Echocardiography; Enalapril; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Receptor, Angiotensin, Type 1; Renal Dialysis | 2002 |
Changes in pain perception during treatment with angiotensin converting enzyme-inhibitors and angiotensin II type 1 receptor blockade.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Dental Pulp; Electric Stimulation; Enalapril; Humans; Hypertension; Losartan; Male; Middle Aged; Pain; Pain Threshold; Receptor, Angiotensin, Type 1; Reference Values | 2002 |
[Effect of long-term treatment with enalapril, losartan and their combination on the quality of life of patients with congestive heart failure].
Topics: Adult; Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Losartan; Middle Aged; Quality of Life; Receptor, Angiotensin, Type 1 | 2002 |
Effects of combined treatment with enalapril and losartan on myocardial function in heart failure.
Topics: Aged; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Enalapril; Heart Failure; Humans; Losartan; Middle Aged | 2002 |
Effects of enalapril and losartan on circulating adhesion molecules and monocyte chemotactic protein-1.
Topics: Aged; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Cell Adhesion Molecules; Chemokine CCL2; Double-Blind Method; E-Selectin; Enalapril; Enzyme Inhibitors; Female; Humans; Hypertension; Intercellular Adhesion Molecule-1; Losartan; Male; Middle Aged; Prospective Studies; Vascular Cell Adhesion Molecule-1 | 2002 |
Preventing increases in early-morning blood pressure, heart rate, and the rate-pressure product with controlled onset extended release verapamil at bedtime versus enalapril, losartan, and placebo on arising.
Topics: Antihypertensive Agents; Blood Pressure; Circadian Rhythm; Delayed-Action Preparations; Double-Blind Method; Electrocardiography, Ambulatory; Enalapril; Female; Heart Rate; Humans; Hypertension; Losartan; Male; Statistics, Nonparametric; Systole; Verapamil | 2002 |
[Angiotensin II type 1 antagonist suppress left ventricular hypertrophy and myocardial fibrosis in patient with end stage renal disease (ESRD)].
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Cardiomyopathies; Enalapril; Female; Fibrosis; Humans; Hypertrophy, Left Ventricular; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Myocardium; Renal Dialysis | 2002 |
Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Creatinine; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Losartan; Male; Postoperative Complications; Potassium; Proteinuria; Receptor, Angiotensin, Type 1; Uric Acid | 2002 |
Enalapril and losartan reduce sympathetic hyperactivity in patients with chronic renal failure.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cross-Over Studies; Enalapril; Female; Humans; Hypertension; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Muscle, Skeletal; Sympathetic Nervous System | 2003 |
An open comparative clinical trial to assess the efficacy and safety of losartan versus enalapril in mild to moderate hypertension.
Topics: Aged; Antihypertensive Agents; Blood Pressure Determination; Dose-Response Relationship, Drug; Drug Administration Schedule; Enalapril; Female; Follow-Up Studies; Humans; Hypertension; Losartan; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Outcome | 2002 |
ACE-I and ARBs in early diabetic nephropathy.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biopsy; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Double-Blind Method; Enalapril; Female; Humans; Losartan; Male; Personnel Selection; Research Design | 2002 |
Prospective evaluation comparing the effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Radionuclide Ventriculography; Stroke Volume; Ventricular Function, Left; Ventricular Remodeling | 2003 |
Antiproteinuric effects of enalapril and losartan: a pilot study.
Topics: Adolescent; Adult; Antihypertensive Agents; Blood Pressure; Child; Creatinine; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Humans; Losartan; Male; Pilot Projects; Proteinuria; Treatment Outcome | 2003 |
Effects of ACE inhibition and AT1-receptor antagonism on endothelial function and insulin sensitivity in essential hypertensive patients.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Glucose; Blood Pressure; Enalapril; Endothelium, Vascular; Female; Humans; Hypertension; Insulin Resistance; Losartan; Male; Middle Aged; Nitric Oxide; Oxidative Stress; Thiobarbituric Acid Reactive Substances; Vasodilation | 2003 |
Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
Topics: Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Double-Blind Method; Drug Combinations; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Nitrendipine; Treatment Outcome | 2004 |
Bradykinin contributes to the systemic hemodynamic effects of chronic angiotensin-converting enzyme inhibition in patients with heart failure.
Topics: Aged; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Cardiac Output; Cross-Over Studies; Double-Blind Method; Enalapril; Female; Forearm; Heart Failure; Heart Rate; Hemodynamics; Humans; Losartan; Male; Middle Aged; Peptidyl-Dipeptidase A; Regional Blood Flow; Vasodilation | 2004 |
Anti-proteinuric effects of combination therapy with enalapril and losartan in patients with nephropathy due to type 2 diabetes.
Topics: Adult; Aged; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Male; Middle Aged; Proteinuria | 2004 |
Comparison of the effects of angiotensin receptor antagonist, angiotensin converting enzyme inhibitor, and their combination on regression of left ventricular hypertrophy of diabetes type 2 patients on recent onset hemodialysis therapy.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertrophy, Left Ventricular; Losartan; Male; Middle Aged; Renin-Angiotensin System; Treatment Outcome | 2004 |
Effect of enalapril and losartan on cytokines in patients with stable angina pectoris awaiting coronary artery bypass grafting and their interaction with polymorphisms in the interleukin-6 gene.
Topics: Aged; Angina Pectoris; Antihypertensive Agents; Coronary Artery Bypass; Cytokines; Enalapril; Genotype; Humans; Interleukin-6; Losartan; Male; Middle Aged; Polymorphism, Genetic | 2004 |
Angiotensin receptor blockade decreases markers of vascular inflammation.
Topics: Angiotensin Receptor Antagonists; Blood Pressure; Cholesterol; Double-Blind Method; E-Selectin; Enalapril; Enzyme-Linked Immunosorbent Assay; Female; Flow Cytometry; Humans; Hypercholesterolemia; Inflammation; Intercellular Adhesion Molecule-1; Leukocytes; Losartan; Male; Middle Aged; Pilot Projects; Receptors, Angiotensin; Vascular Cell Adhesion Molecule-1; Vascular Diseases | 2004 |
Combined therapy of enalapril and losartan attenuates histologic progression in immunoglobulin A nephropathy.
Topics: Adolescent; Antihypertensive Agents; Biopsy; Child; Creatinine; Disease Progression; Drug Therapy, Combination; Enalapril; Female; Glomerulonephritis, IGA; Humans; Japan; Kidney; Losartan; Male; Pilot Projects; Proteinuria; Treatment Outcome | 2004 |
The effect of an angiotensin-converting enzyme inhibitor and a K+(ATP) channel opener on warm up angina.
Topics: Adaptation, Physiological; Angina Pectoris; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Cross-Over Studies; Double-Blind Method; Electrocardiography; Enalapril; Exercise Test; Female; Humans; Ischemic Preconditioning, Myocardial; Losartan; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Potassium Channels; Regression Analysis; Vasodilator Agents | 2005 |
B1 kinin receptor does not contribute to vascular tone or tissue plasminogen activator release in the peripheral circulation of patients with heart failure.
Topics: Adolescent; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Bradykinin B1 Receptor Antagonists; Cross-Over Studies; Enalapril; Female; Fibrinolysis; Forearm; Heart Failure; Humans; In Vitro Techniques; Kallidin; Losartan; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Pregnancy; Receptor, Bradykinin B1; Regional Blood Flow; Tissue Plasminogen Activator; Umbilical Veins; Vasoconstriction | 2005 |
Low-dose angiotensin II receptor antagonists and angiotensin II-converting enzyme inhibitors alone or in combination for treatment of primary glomerulonephritis.
Topics: Adult; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chronic Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Enalapril; Female; Follow-Up Studies; Glomerulonephritis; Humans; Kidney Function Tests; Losartan; Male; Middle Aged; Prospective Studies; Reference Values; Severity of Illness Index; Statistics, Nonparametric; Treatment Outcome | 2004 |
Randomized, controlled study of the effects of losartan versus enalapril in small doses on proteinuria and tubular injury in primary glomerulonephritis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Blood Pressure; Creatinine; Enalapril; Female; Glomerulonephritis; Humans; Kidney Tubules; Losartan; Male; Proteinuria | 2005 |
Renoprotective effect of early inhibition of the renin-angiotensin system in renal transplant recipients.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Creatinine; Enalapril; Follow-Up Studies; Humans; Hypertension; Kidney Function Tests; Kidney Transplantation; Losartan; Proteinuria; Ramipril; Renal Artery; Renin-Angiotensin System; Tetrazoles; Time Factors; Valine; Valsartan | 2005 |
[Changes of serum asymmetric dimethylarginine in essential hypertension before and after the treatment].
Topics: Adult; Aged; Antihypertensive Agents; Arginine; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Nitric Oxide; Nitric Oxide Synthase | 2005 |
Comparison of the effect of enalapril and losartan in conjunction with surgical coronary revascularisation versus revascularisation alone on systemic endothelial function.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Coronary Artery Disease; Double-Blind Method; Enalapril; Endothelium, Vascular; Genotype; Humans; Losartan; Male; Middle Aged; Mutation; Myocardial Infarction; Myocardial Revascularization; Risk Assessment; Risk Factors | 2005 |
Enalapril suppresses ventricular remodeling more effectively than losartan in patients with acute myocardial infarction.
Topics: Angioplasty, Balloon, Coronary; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Ventricular Function, Left; Ventricular Remodeling | 2005 |
Serum concentration of potassium in chronic heart failure patients administered spironolactone plus furosemide and either enalapril maleate, losartan potassium or candesartan cilexetil.
Topics: Adult; Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Enalapril; Female; Furosemide; Heart Failure; Humans; Hyperkalemia; Losartan; Male; Middle Aged; Potassium; Sodium Potassium Chloride Symporter Inhibitors; Spironolactone | 2005 |
Impact of the angiotensin II receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: assessment by ultrasonic integrated backscatter and biochemical markers.
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Collagen; Double-Blind Method; Echocardiography; Enalapril; Female; Fibrosis; Humans; Kidney Failure, Chronic; Losartan; Male; Middle Aged; Myocardium; Peptide Fragments; Procollagen | 2005 |
Dual blockade of angiotensin II with enalapril and losartan reduces proteinuria in hypertensive patients with type 2 diabetes.
Topics: Aged; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; C-Reactive Protein; Cystatin C; Cystatins; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Natriuretic Peptide, Brain; Proteinuria; Transforming Growth Factor beta | 2006 |
Treatments with losartan or enalapril are equally sensitive to deterioration in renal function from cyclooxygenase inhibition.
Topics: Aged; Aged, 80 and over; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Bradykinin; Cyclooxygenase 2 Inhibitors; Diclofenac; Diuretics; Enalapril; Female; Glomerular Filtration Rate; Heart Failure; Humans; Kidney; Losartan; Male; Middle Aged; Renin-Angiotensin System; Time Factors | 2007 |
Effects of monotherapy and combination therapy on blood pressure control and target organ damage: a randomized prospective intervention study in a large population of hypertensive patients.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Carbazoles; Cardiovascular Diseases; Carvedilol; Drug Therapy, Combination; Enalapril; Humans; Hypertension; Losartan; Male; Middle Aged; Propanolamines; Ultrasonography | 2006 |
The relation of ambulatory blood pressure and pulse rate to retinopathy in type 1 diabetes mellitus: the renin-angiotensin system study.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cross-Sectional Studies; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Double-Blind Method; Enalapril; Female; Glomerular Filtration Rate; Heart Rate; Humans; Losartan; Male; Renin-Angiotensin System | 2006 |
Effects of ACE inhibition and angiotensin II receptor blockade on glomerular basement membrane protein excretion and charge selectivity in type 2 diabetic patients.
Topics: Acetylglucosaminidase; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Collagen Type IV; Diabetes Mellitus, Type 2; Enalapril; Extracellular Matrix Proteins; Female; Fibronectins; Glomerular Basement Membrane; Humans; Hypertension; Losartan; Male; Middle Aged | 2006 |
Enalapril and losartan affect lipid peroxidation in renal transplant recipients with renin-angiotensin system polymorphisms.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Cross-Over Studies; Enalapril; Female; Humans; Kidney Transplantation; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sequence Analysis, DNA | 2007 |
Renin-angiotensin system polymorphisms and hemoglobin level in renal allografts: a comparative study between losartan and enalapril.
Topics: Adult; Angiotensinogen; Antihypertensive Agents; Enalapril; Female; Hemoglobins; Humans; Kidney Transplantation; Losartan; Male; Peptidyl-Dipeptidase A; Polymerase Chain Reaction; Polymorphism, Genetic; Renin-Angiotensin System | 2007 |
Prevention of DNA damage in renal transplantation by losartan and enalapril: the role of renin-angiotensin system polymorphisms.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Ataxia Telangiectasia Mutated Proteins; Biomarkers; Cell Cycle Proteins; Deoxyguanosine; DNA Damage; Enalapril; Female; Humans; Kidney Transplantation; Lipid Peroxidation; Losartan; Male; Malondialdehyde; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Protein Serine-Threonine Kinases; Renin-Angiotensin System | 2008 |
Losartan decreased premature ventricular contractions in patients with hypertension.
Topics: Aged; Amlodipine; Anti-Arrhythmia Agents; Enalapril; Humans; Hypertension; Losartan; Middle Aged; Ventricular Premature Complexes | 2009 |
Efficacy of exercise, losartan, enalapril, atenolol and rilmenidine in subjects with blood pressure hyperreactivity at treadmill stress test and left ventricular hypertrophy.
Topics: Adult; Antihypertensive Agents; Atenolol; Blood Pressure; Enalapril; Exercise Test; Exercise Therapy; Female; Humans; Hypertrophy, Left Ventricular; Losartan; Male; Oxazoles; Renin-Angiotensin System; Rilmenidine; Sympathetic Nervous System | 2009 |
Beneficial effects of high-dose losartan in IgA nephritis.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Dose-Response Relationship, Drug; Enalapril; Female; Glomerular Filtration Rate; Glomerulonephritis, IGA; Humans; Losartan; Male; Treatment Outcome | 2009 |
Effects of enalapril and losartan in left ventricular remodeling after acute myocardial infarction: a possible mechanism of prevention of cardiac events by angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in high-risk myocardial
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Cardiotonic Agents; Enalapril; Female; Humans; Losartan; Male; Middle Aged; Myocardial Infarction; Receptors, Angiotensin; Risk Factors; Ventricular Remodeling | 2009 |
Renal and retinal effects of enalapril and losartan in type 1 diabetes.
Topics: Adult; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Diabetic Retinopathy; Disease Progression; Double-Blind Method; Enalapril; Female; Follow-Up Studies; Glomerular Filtration Rate; Humans; Kaplan-Meier Estimate; Kidney Glomerulus; Logistic Models; Losartan; Male; Mesangial Cells; Renin-Angiotensin System; Retina | 2009 |
Renoprotect and blood pressure lowering effect of low-dose hydrochlorothiazide added to intensive renin-angiotensin inhibition in hypertensive patients with chronic kidney disease.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Chronic Disease; Creatinine; Drug Administration Schedule; Drug Combinations; Enalapril; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney Diseases; Losartan; Male; Middle Aged | 2009 |
Effect of enalapril and losartan on proteinuria in type 2 diabetic nephropathy patients.
Topics: Aged; Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Enalapril; Humans; Losartan; Middle Aged; Prospective Studies; Proteinuria | 2009 |
Relationship of blood pressure to retinal vessel diameter in type 1 diabetes mellitus.
Topics: Adolescent; Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arterioles; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Diabetes Mellitus, Type 1; Double-Blind Method; Enalapril; Female; Glycated Hemoglobin; Heart Rate; Humans; Image Processing, Computer-Assisted; Losartan; Male; Middle Aged; Retinal Vessels; Venules | 2010 |
Dual blockade of the renin-angiotensin-aldosterone system is safe and effective in reducing albuminuria in Asian type 2 diabetic patients with nephropathy.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Asian People; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Male; Middle Aged | 2010 |
Addition of losartan to angiotensin-converting enzyme inhibitors improves insulin resistance in patients with chronic heart failure treated without β-blockers.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Blood Glucose; Chemokine CCL2; Chronic Disease; Cross-Over Studies; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Imidazolidines; Inflammation Mediators; Insulin; Insulin Resistance; Interleukin-6; Japan; Lisinopril; Losartan; Male; Middle Aged; Time Factors; Treatment Outcome; Tumor Necrosis Factor-alpha | 2010 |
FGF-23 as a predictor of renal outcome in diabetic nephropathy.
Topics: Aged; Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Brazil; Chi-Square Distribution; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Progression; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Fibroblast Growth Factor-23; Fibroblast Growth Factors; Humans; Kaplan-Meier Estimate; Losartan; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome | 2011 |
Effect of diet, enalapril, or losartan in post-diarrheal hemolytic uremic syndrome nephropathy.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Diarrhea; Diet Therapy; Double-Blind Method; Enalapril; Female; Hemolytic-Uremic Syndrome; Humans; Kidney Failure, Chronic; Losartan; Male; Proteinuria | 2011 |
Benefits of Renin-Angiotensin blockade on retinopathy in type 1 diabetes vary with glycemic control.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Blood Glucose; Diabetes Mellitus, Type 1; Diabetic Retinopathy; Enalapril; Female; Glycated Hemoglobin; Humans; Losartan; Male; Renin-Angiotensin System; Young Adult | 2011 |
ACEI and ARB combination therapy in patients with macroalbuminuric diabetic nephropathy and low socioeconomic level: a double-blind randomized clinical trial.
Topics: Analysis of Variance; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Chi-Square Distribution; Diabetic Nephropathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Logistic Models; Losartan; Male; Middle Aged; Proteinuria; Social Class; Treatment Outcome | 2011 |
Losartan and enalapril are comparable in reducing proteinuria in children.
Topics: Adolescent; Age Factors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Biomarkers; Child; Child, Preschool; Creatinine; Cystatin C; Enalapril; Female; Glomerular Filtration Rate; Humans; Least-Squares Analysis; Losartan; Male; Proteinuria; Renal Insufficiency, Chronic; Time Factors; Treatment Outcome | 2012 |
Losartan and enalapril are comparable in reducing proteinuria in children with Alport syndrome.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Asia; Biomarkers; Child; Child, Preschool; Creatinine; Double-Blind Method; Enalapril; Europe; Female; Glomerular Filtration Rate; Humans; Infant; Kidney; Least-Squares Analysis; Losartan; Male; Nephritis, Hereditary; Proteinuria; South America; Time Factors; Treatment Outcome; United States | 2013 |
Inhibition of the renin-angiotensin system does not reduce platelet activity at rest or during stress in hypertension.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Coagulation; Blood Platelets; Cross-Over Studies; Double-Blind Method; Enalapril; Endothelium, Vascular; Exercise Test; Female; Flow Cytometry; Humans; Hypertension; Inflammation; Losartan; Male; Middle Aged; Placebos; Renin-Angiotensin System; Treatment Outcome | 2013 |
Long-term hemodynamic and molecular effects persist after discontinued renin-angiotensin system blockade in patients with type 1 diabetes mellitus.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Chemokines; Cytokines; Diabetes Mellitus, Type 1; Diabetic Angiopathies; Drug Administration Schedule; Enalapril; Endothelium, Vascular; Female; Hemodynamics; Humans; Losartan; Male; Middle Aged; Ontario; Oxidative Stress; Renin-Angiotensin System; Skin; Time Factors; Treatment Outcome; Vascular Stiffness | 2013 |
Randomized trial of perindopril, enalapril, losartan and telmisartan in overweight or obese patients with hypertension.
Topics: Adult; Antihypertensive Agents; Benzimidazoles; Benzoates; Blood Pressure; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Obesity; Overweight; Perindopril; Single-Blind Method; Telmisartan | 2013 |
Adherence and renal biopsy feasibility in the Renin Angiotensin-System Study (RASS) primary prevention diabetes trial.
Topics: Adolescent; Adult; Antihypertensive Agents; Biopsy; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enalapril; Female; Humans; Kidney; Losartan; Male; Middle Aged; Patient Compliance; Primary Prevention | 2013 |
Prospective randomized study of the tolerability and efficacy of combination therapy for hypertensive chronic kidney disease: results of the PROTECT-CKD study.
Topics: Adult; Aged; Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension, Renal; Losartan; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Young Adult | 2015 |
Comparison of Effect of Enalapril and Losartan Monotherapy on Quality of Life and Safety of Stage 1 Hypertensive Patients.
Topics: Antihypertensive Agents; Blood Pressure; Enalapril; Female; Humans; Hypertension; Kidney Function Tests; Liver Function Tests; Losartan; Male; Middle Aged; Quality of Life; Severity of Illness Index; Surveys and Questionnaires | 2016 |
Effects of losartan and enalapril on serum uric acid and GFR in children with proteinuria.
Topics: Adult; Antihypertensive Agents; Child; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Losartan; Prospective Studies; Proteinuria; Uric Acid | 2021 |
Aerobic Physical Exercise is Essential for Cardiac Autonomic Regulation in Hypertensive Patients Undergoing Chronic Treatment with Renin- Angiotensin System Inhibitors.
Topics: Adult; Angiotensins; Antihypertensive Agents; Blood Pressure; Enalapril; Exercise; Heart Rate; Humans; Hypertension; Losartan; Male; Middle Aged; Renin | 2023 |
277 other study(ies) available for losartan and enalapril
| Article | Year |
|---|---|
Interaction of digoxin with antihypertensive drugs via MDR1.
Topics: Animals; Antihypertensive Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Biological Transport; Cells, Cultured; Digoxin; Drug Interactions; Humans; Time Factors | 2002 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Hologram QSAR model for the prediction of human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Holography; Humans; Models, Biological; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2007 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
How well can the Caco-2/Madin-Darby canine kidney models predict effective human jejunal permeability?
Topics: Animals; Disease Models, Animal; Dogs; Humans; Jejunal Diseases; Kidney Diseases; Models, Biological; Permeability; Porosity; Regression Analysis | 2010 |
Lipophilicity of acidic compounds: impact of ion pair partitioning on drug design.
Topics: Acids; Albumins; Drug Design; Humans; Hydrogen-Ion Concentration; Lipids; Molecular Structure; Pharmaceutical Preparations; Protein Binding | 2011 |
Discovery of potent, selective multidrug and toxin extrusion transporter 1 (MATE1, SLC47A1) inhibitors through prescription drug profiling and computational modeling.
Topics: Computer Simulation; Fluorescent Dyes; Organic Cation Transport Proteins; Prescription Drugs | 2013 |
The role of the renin-angiotensin system in the control of cell communication in the heart: effects of enalapril and angiotensin II.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Bradykinin; Cell Communication; Enalapril; Heart; Imidazoles; In Vitro Techniques; Losartan; Membrane Potentials; Protein Kinase C; Protein Kinases; Rats; Renin-Angiotensin System; Tetrazoles | 1992 |
The antihypertensive effect of the angiotensin II receptor antagonist DuP 753 may not be due solely to angiotensin II receptor antagonism.
Topics: Acrylates; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Captopril; Decerebrate State; Enalapril; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred Strains; Receptors, Angiotensin; Spinal Cord; Tetrazoles; Thiophenes | 1992 |
Effect of ANG II receptor antagonist on albuminuria and renal function in passive Heymann nephritis.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Enalapril; Glomerulonephritis; Imidazoles; Kidney; Losartan; Male; Rats; Rats, Inbred Strains; Renin; Serum Albumin; Tetrazoles | 1992 |
Comparison of systemic and regional hemodynamic effects of a diuretic, an angiotensin II receptor antagonist, and an angiotensin-converting enzyme inhibitor in conscious renovascular hypertensive rats.
Topics: Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Consciousness; Enalapril; Furosemide; Hemodynamics; Hypertension, Renovascular; Imidazoles; Kidney; Losartan; Male; Rats; Skin; Skin Physiological Phenomena; Spleen; Stomach; Tetrazoles; Vascular Resistance | 1992 |
Renal functional reserve in the early stage of experimental diabetes.
Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Diabetes Mellitus, Experimental; Enalapril; Glomerular Filtration Rate; Glycine; Hydrostatic Pressure; Imidazoles; Kidney; Kidney Glomerulus; Kidney Tubules; Losartan; Male; Nephrons; Rats; Rats, Inbred Strains; Reference Values; Renal Circulation; Tetrazoles | 1992 |
Angiotensin II and left ventricular growth in newborn pig heart.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Newborn; Biphenyl Compounds; DNA; Enalapril; Heart Ventricles; Imidazoles; Losartan; Proteins; RNA; Swine; Tetrazoles | 1991 |
Roles of renal and vascular renin in spontaneous hypertension and switching of the mechanism upon nephrectomy. Lack of hypotensive effects of inhibition of renin, converting enzyme, and angiotensin II receptor blocker after bilateral nephrectomy.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enalapril; Hypertension; Hypotension; Imidazoles; Immunoglobulin G; Indans; Losartan; Nephrectomy; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renin; Tetrazoles; Time Factors | 1991 |
Effects of the angiotensin II receptor antagonist losartan on 24-hour blood pressure profiles of primary and secondary hypertensive rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Circadian Rhythm; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Tetrazoles | 1995 |
Is estrogen-induced pituitary hyperplasia and hyperprolactinaemia mediated by angiotensin II?
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Cell Division; Diethylstilbestrol; Enalapril; Enalaprilat; Estrogens; Estrogens, Non-Steroidal; Humans; Hyperpituitarism; Hyperplasia; Hyperprolactinemia; Imidazoles; Losartan; Prolactin; Pyridines; Rats; Rats, Inbred F344; Rats, Wistar; Tetrazoles; Tumor Cells, Cultured | 1995 |
Prevention of experimental cyclosporin-induced interstitial fibrosis by losartan and enalapril.
Topics: Animals; Biphenyl Compounds; Blood Pressure; Cyclosporine; Enalapril; Furosemide; Hydralazine; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Microscopy, Electron, Scanning; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Tetrazoles | 1995 |
Role of angiotensin in pressure overload-induced hypertrophy in rats: effects of angiotensin-converting enzyme inhibitors, an AT1 receptor antagonist, and surgical reversal.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Biphenyl Compounds; Blood Pressure; Body Weight; Cardiomegaly; Enalapril; Heart Ventricles; Imidazoles; Losartan; Male; Organ Size; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles; Ventricular Function | 1994 |
Endogenous vasoactive systems and the pressor effect of acute N omega-nitro-L-arginine methyl ester administration.
Topics: Adrenergic alpha-Antagonists; Angiotensin II; Animals; Arginine; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Diet, Sodium-Restricted; Enalapril; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nicardipine; Nitric Oxide; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Vasoconstriction | 1994 |
Comparative effects of losartan, captopril, and enalapril on murine acute myocarditis due to encephalomyocarditis virus.
Topics: Acute Disease; Administration, Oral; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Body Weight; Captopril; Cardiovirus Infections; Enalapril; Encephalomyocarditis virus; Female; Heart; Heart Failure; Hypertrophy, Left Ventricular; Imidazoles; Injections, Intraperitoneal; Losartan; Mice; Mice, Inbred C3H; Myocarditis; Myocardium; Organ Size; Random Allocation; Tetrazoles; Therapeutic Equivalency | 1995 |
Comparison of the transplacental transfer of enalapril, captopril and losartan in sheep.
Topics: Angiotensin I; Angiotensin Receptor Antagonists; Animals; Biological Transport; Biphenyl Compounds; Blood Pressure; Captopril; Enalapril; Female; Fetus; Imidazoles; Injections, Intravenous; Losartan; Placenta; Sheep; Tetrazoles | 1995 |
Effects of chronic treatment with angiotensin converting enzyme inhibitor or an angiotensin receptor antagonist in two-kidney, one-clip hypertensive rats.
Topics: Albuminuria; Analysis of Variance; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Body Weight; Enalapril; Hemodynamics; Hypertension, Renovascular; Imidazoles; Kidney; Losartan; Male; Organ Size; Random Allocation; Rats; Rats, Wistar; Tetrazoles | 1995 |
Efficacy of SR 47436 (BMS-186295), a non-peptide angiotensin AT1 receptor antagonist in hypertensive rat models.
Topics: Administration, Oral; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Tolerance; Enalapril; Hypertension, Renal; Imidazoles; Injections, Intravenous; Irbesartan; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Rats, Sprague-Dawley; Renin; Renin-Angiotensin System; Tachycardia; Tetrazoles | 1994 |
In vivo pharmacology of a novel AT1 selective angiotensin II receptor antagonist, MK-996.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Bradykinin; Dogs; Enalapril; Female; Imidazoles; Injections, Intravenous; Losartan; Macaca mulatta; Male; Nitroglycerin; Pan troglodytes; Pyridines; Rats; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Comparison of the effects of angiotensin II, losartan, and enalapril on baroreflex control of heart rate in conscious rabbits.
Topics: Angiotensin II; Animals; Baroreflex; Biphenyl Compounds; Blood Pressure; Enalapril; Female; Heart Rate; Imidazoles; In Vitro Techniques; Losartan; Male; Rabbits; Tetrazoles | 1995 |
The renin-angiotensin system and volume overload-induced changes in cardiac collagen and elastin.
Topics: Aging; Animals; Biphenyl Compounds; Blood Pressure; Collagen; Coronary Circulation; Elastin; Enalapril; Heart Ventricles; Hyperemia; Imidazoles; Losartan; Male; Minoxidil; Myocardium; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles | 1994 |
Juxtaglomerular cell hypertrophy and hyperplasia induced in rhesus monkeys by angiotensin II receptor antagonists.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Dose-Response Relationship, Drug; Enalapril; Hyperplasia; Hypertrophy; Imidazoles; Immunosuppressive Agents; Juxtaglomerular Apparatus; Losartan; Macaca mulatta; Pyridines; Renin; Tetrazoles; Time Factors | 1994 |
Effects of enalapril versus losartan on regression of volume overload-induced cardiac hypertrophy in rats.
Topics: Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Volume; Body Weight; Cardiomegaly; Coronary Circulation; Enalapril; Heart Ventricles; Hematocrit; Hemodynamics; Hyperemia; Imidazoles; Losartan; Male; Minoxidil; Myocardium; Organ Size; Rats; Rats, Wistar; Tetrazoles | 1994 |
Effects of enalapril and Dup753 on renin synthesis in mice with one hydronephrotic kidney.
Topics: Animals; Antihypertensive Agents; Biphenyl Compounds; Enalapril; Hydronephrosis; Imidazoles; Kidney; Kidney Tubules, Distal; Losartan; Male; Mice; Mice, Inbred BALB C; Renin; RNA, Messenger; Tetrazoles | 1994 |
Effect of losartan and enalapril on renal adaptation sodium restriction in rat.
Topics: Adaptation, Physiological; Aldosterone; Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Diet, Sodium-Restricted; Enalapril; Hemodynamics; Imidazoles; Kallikreins; Kidney; Losartan; Male; Natriuresis; Rats; Rats, Sprague-Dawley; Renal Circulation; Renin-Angiotensin System; Systole; Tetrazoles | 1994 |
Effect of sodium chloride, enalapril, and losartan on the development of polycystic kidney disease in Han:SPRD rats.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Creatinine; Enalapril; Female; Imidazoles; Losartan; Male; Polycystic Kidney Diseases; Rats; Rats, Sprague-Dawley; Renin; Sodium Chloride; Tetrazoles | 1994 |
Prevention of thromboxane A2 receptor-mediated pulmonary hypertension by a nonpeptide angiotensin II type 1 receptor antagonist.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Enalapril; Fatty Acids, Unsaturated; Hematocrit; Hydrazines; Hypertension, Pulmonary; Imidazoles; Losartan; Male; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Sprague-Dawley; Receptors, Thromboxane; Tetrazoles; Thromboxane A2 | 1994 |
Cardiac hypertrophy and brain natriuretic peptide in experimental hypertension.
Topics: Animals; Atrial Natriuretic Factor; Biphenyl Compounds; Blood Pressure; Blood Urea Nitrogen; Cardiomegaly; Chromatography, High Pressure Liquid; Creatinine; Desoxycorticosterone; Enalapril; Heart; Hydralazine; Hypertension, Malignant; Imidazoles; Losartan; Male; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Rats; Rats, Inbred SHR; Sodium, Dietary; Tetrazoles | 1994 |
Kinins contribute to the improvement of insulin sensitivity during treatment with angiotensin converting enzyme inhibitor.
Topics: Analysis of Variance; Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Glucose; Blood Pressure; Body Weight; Bradykinin; Doxazosin; Enalapril; Glucose Clamp Technique; Hypertension; Imidazoles; Insulin; Kinins; Losartan; Male; Potassium; Rats; Rats, Inbred SHR; Sodium; Tetrazoles | 1994 |
Renin-angiotensin system in the pressor effect of acute N-omega-nitro-L-arginine methyl ester.
Topics: Animals; Arginine; Biphenyl Compounds; Blood Pressure; Desoxycorticosterone; Enalapril; Heart Rate; Imidazoles; Losartan; Male; Nephrectomy; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles | 1993 |
Comparative effects of chronic angiotensin-converting enzyme inhibition and angiotensin II type 1 receptor blockade on cardiac remodeling after myocardial infarction in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Coronary Circulation; Enalapril; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Tetrazoles; Time Factors | 1994 |
Renin-angiotensin system and minoxidil-induced cardiac hypertrophy in rats.
Topics: Angiotensin II; Animals; Biphenyl Compounds; Blood Pressure; Cardiomegaly; Enalapril; Heart; Hemodynamics; Imidazoles; Losartan; Male; Minoxidil; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Ventricular Function, Left | 1993 |
Angiotensin II receptor blockade improves renal function in rats with reduced renal mass.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Kidney; Losartan; Male; Nicotinic Acids; Organ Size; Proteinuria; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Renin; Tetrazoles | 1993 |
Chronic converting enzyme inhibition facilitates baroreceptor resetting to hypertensive levels.
Topics: Angiotensin I; Angiotensin II; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Bradykinin; Captopril; Enalapril; Hypertension; Imidazoles; Losartan; Male; Pressoreceptors; Rats; Rats, Wistar; Reference Values; Regression Analysis; Tetrazoles | 1994 |
Effects of an angiotensin II receptor antagonist on the progression of renal failure in hyperlipidemic Imai rats.
Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Blood Urea Nitrogen; Cholesterol; Disease Models, Animal; Enalapril; Glomerulonephritis; Hyperlipidemias; Imidazoles; Kidney; Kidney Failure, Chronic; Losartan; Male; Organ Size; Proteinuria; Rats; Renin-Angiotensin System; Serum Albumin; Tetrazoles | 1993 |
Effect of angiotensin II blockade on dietary protein-induced renal growth.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Dietary Proteins; Enalapril; Hypertrophy; Imidazoles; Kidney; Losartan; Male; Organ Size; Rats; Rats, Sprague-Dawley; Tetrazoles | 1993 |
In vivo pharmacology of SC-51316, a nonpeptidic angiotensin II receptor antagonist.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Pressure; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles; Triazoles | 1993 |
The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker.
Topics: Angiotensin II; Animals; Aorta; Arteriovenous Shunt, Surgical; Biphenyl Compounds; Body Weight; Cardiac Volume; Cardiomegaly; Enalapril; Hemodynamics; Imidazoles; Losartan; Male; Myocardium; Organ Size; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Tetrazoles; Venae Cavae | 1993 |
Pharmacology of XR510, a potent orally active nonpeptide angiotensin II AT1 receptor antagonist with high affinity for the AT2 receptor subtype.
Topics: 1-Sarcosine-8-Isoleucine Angiotensin II; Administration, Oral; Adrenal Glands; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Binding, Competitive; Biphenyl Compounds; Blood Pressure; Decerebrate State; Dogs; Enalapril; Female; Guinea Pigs; Humans; Hypertension, Renal; Imidazoles; Injections, Intravenous; Losartan; Male; Rabbits; Radioligand Assay; Rats; Rats, Inbred SHR; Rats, Sprague-Dawley; Tetrazoles | 1995 |
Losartan-induced azotemia in a diabetic recipient of a kidney transplant.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Diabetes Mellitus, Type 1; Enalapril; Humans; Imidazoles; Kidney Transplantation; Losartan; Male; Middle Aged; Tetrazoles; Uremia | 1996 |
Neuroendocrine and cardiovascular effects of serotonin: selective role of brain angiotensin on vasopressin.
Topics: Adrenocorticotropic Hormone; Analysis of Variance; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Arginine Vasopressin; Biphenyl Compounds; Blood Pressure; Cerebral Ventricles; Corticosterone; Enalapril; Ergolines; Fenfluramine; Heart Rate; Imidazoles; Injections, Intraventricular; Losartan; Male; Oxytocin; Prolactin; Rats; Rats, Sprague-Dawley; Renin; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Tetrazoles | 1996 |
Renin-angiotensin system and cell communication in the failing heart.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Cells, Cultured; Cricetinae; Enalapril; Gap Junctions; Heart Conduction System; Heart Failure; Imidazoles; Losartan; Male; Membrane Potentials; Mesocricetus; Patch-Clamp Techniques; Renin-Angiotensin System; Tetrazoles | 1996 |
Role of ANG II in hypertension produced by chronic inhibition of nitric oxide synthase in conscious rats.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Enalapril; Hypertension; Imidazoles; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley; Reference Values; Tetrazoles; Time Factors | 1996 |
Role of aldosterone in the remnant kidney model in the rat.
Topics: Adrenal Glands; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Body Weight; Disease Models, Animal; Enalapril; Imidazoles; Kidney; Kidney Diseases; Losartan; Male; Mineralocorticoid Receptor Antagonists; Nephrectomy; Organ Size; Rats; Rats, Sprague-Dawley; Spironolactone; Tetrazoles | 1996 |
ME3221, a surmountable angiotensin AT1-receptor antagonist, prevents hypertensive complications in aged stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Brain; Cerebrovascular Disorders; Enalapril; Heart; Hypertension; Imidazoles; Kidney; Losartan; Male; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles | 1996 |
Modulators of the renin-angiotensin-aldosterone system and cough in childhood.
Topics: Adolescent; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Child; Cough; Enalapril; Female; Humans; Imidazoles; Losartan; Male; Renin-Angiotensin System; Tetrazoles | 1996 |
Renal function in one-kidney, one clip sodium-restricted rats: influence of enalapril and losartan.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Enalapril; Hemodynamics; Hypertension; Imidazoles; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 1995 |
Combined heart failure treatment with ACE inhibition and AT1-receptor blockade.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biphenyl Compounds; Cardiac Output, Low; Drug Therapy, Combination; Enalapril; Humans; Imidazoles; Losartan; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1996 |
Protective effects of ME3221 on hypertensive complications and lifespan in salt-loaded stroke-prone spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Body Weight; Cerebral Hemorrhage; Dose-Response Relationship, Drug; Enalapril; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
Antinociceptive effects of angiotensin-converting enzyme inhibitors and an angiotensin II receptor antagonist in mice.
Topics: Administration, Oral; Analgesics; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Brain; Enalapril; Imidazoles; Indoles; Losartan; Male; Mice; Naloxone; Pain Measurement; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Tetrazoles | 1996 |
Inhibition of aminopeptidase A activity causes an acute albuminuria in mice: an angiotensin II-mediated effect?
Topics: Acute Disease; Albuminuria; Aminopeptidases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Enalapril; Glutamyl Aminopeptidase; Histocytochemistry; Imidazoles; In Situ Hybridization; Losartan; Mice; Mice, Inbred BALB C; Tetrazoles | 1996 |
Autoregulation of total and zonal glomerular filtration rate in spontaneously hypertensive rats during antihypertensive therapy.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biphenyl Compounds; Calcium Channel Blockers; Enalapril; Glomerular Filtration Rate; Hemodynamics; Homeostasis; Hypertension; Imidazoles; Losartan; Male; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Tetrazoles | 1996 |
Regression of left ventricular hypertrophy in experimental renovascular hypertension: diastolic dysfunction depends more on myocardial collagen than it does on myocardial mass.
Topics: Animals; Biphenyl Compounds; Blood Pressure; Collagen; Diastole; Enalapril; Hypertension, Renovascular; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Tetrazoles | 1996 |
Enalapril and losartan reduced cardiac mass and improved coronary hemodynamics in SHR.
Topics: Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Biphenyl Compounds; Blood Pressure; Coronary Circulation; Dipyridamole; Enalapril; Heart; Hemodynamics; Hypertrophy, Left Ventricular; Imidazoles; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles; Vasodilator Agents | 1997 |
Effect of angiotensin receptor blockade in the rabbit aorta: influence of the endothelium.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Aorta, Thoracic; Biphenyl Compounds; Enalapril; Endothelium, Vascular; Imidazoles; Losartan; Male; Pyridines; Rabbits; Receptors, Angiotensin; Tetrazoles | 1996 |
Angiotensin II responses in AT1A receptor-deficient mice: a role for AT1B receptors in blood pressure regulation.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Enalapril; Hexamethonium; Imidazoles; Kidney; Losartan; Mice; Mice, Knockout; Phentolamine; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin; RNA, Messenger; Sympatholytics; Tetrazoles; Time Factors; Transcription, Genetic | 1997 |
Deterioration in renal function with enalapril but not losartan in a patient with renal artery stenosis in a solitary kidney.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Enalapril; Humans; Imidazoles; Kidney Failure, Chronic; Losartan; Male; Renal Artery Obstruction; Tetrazoles | 1997 |
Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Experimental; Disease Models, Animal; Enalapril; Glucose; Hypertension; Imidazoles; Losartan; Male; Rats; Rats, Inbred Strains; Tetrazoles; Verapamil | 1997 |
Load-induced growth responses in isolated adult rat hearts. Role of the AT1 receptor.
Topics: Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Enalapril; Gene Expression; Heart; Hemodynamics; Imidazoles; In Vitro Techniques; Losartan; Male; Myocardium; Phenylalanine; Protein Biosynthesis; Proto-Oncogenes; Rats; Rats, Wistar; Receptors, Angiotensin; Stress, Mechanical; Systole; Tetrazoles | 1997 |
Protective effect of the angiotensin-converting enzyme inhibitor captopril on postischemic myocardial damage in perfused rat heart.
Topics: Adenine Nucleotides; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Biphenyl Compounds; Blood Pressure; Captopril; Coronary Circulation; Enalapril; Energy Metabolism; Heart Rate; Imidazoles; In Vitro Techniques; Lactic Acid; Losartan; Male; Myocardial Reperfusion Injury; Myocardium; Phosphocreatine; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Tetrazoles | 1997 |
ANG II prolongs splanchnic nerve-mediated inhibition of duodenal mucosal alkaline secretion in the rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Biphenyl Compounds; Duodenum; Electric Stimulation; Enalapril; Hydrogen-Ion Concentration; Imidazoles; In Vitro Techniques; Intestinal Mucosa; Losartan; Male; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Splanchnic Nerves; Tetrazoles; Time Factors | 1997 |
Losartan prevents thromboxane A2/prostanoid (TP) receptor mediated increase in microvascular permeability in the rat.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Bridged Bicyclo Compounds, Heterocyclic; Capillary Permeability; Enalapril; Fatty Acids, Unsaturated; Hematocrit; Hydrazines; Losartan; Male; Microcirculation; Plasma Volume; Prostaglandins; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Receptors, Thromboxane; Serum Albumin; Vasoconstrictor Agents | 1997 |
Molecular mechanism of angiotensin II type I and type II receptors in cardiac hypertrophy of spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Body Weight; Cardiomegaly; Dose-Response Relationship, Drug; Down-Regulation; Enalapril; Imidazoles; Losartan; Male; Myocardium; Organ Size; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger | 1997 |
Role of angiotensin II in the regulation of a novel vascular modulator, hepatocyte growth factor (HGF), in experimental hypertensive rats.
Topics: Aging; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Biphenyl Compounds; Blood Pressure; Enalapril; Gene Expression Regulation, Developmental; Heart; Hepatocyte Growth Factor; Humans; Hypertension; Imidazoles; Losartan; Lung; Male; Myocardium; Organ Specificity; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Regression Analysis | 1997 |
AT1 and AT2 receptor blockade and epinephrine release during insulin-induced hypoglycemia.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Enalapril; Epinephrine; Heart Rate; Humans; Hypoglycemia; Imidazoles; Insulin; Kinetics; Losartan; Male; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 1998 |
Additive effects of enalapril and losartan in (mREN-2)27 transgenic rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Animals, Genetically Modified; Antihypertensive Agents; Blood Pressure; Dose-Response Relationship, Drug; Drug Synergism; Enalapril; Heart; Hemodynamics; Losartan; Male; Mice; Organ Size; Rats; Renin; Renin-Angiotensin System | 1998 |
Angiotensin I-converting enzyme inhibition but not angiotensin II suppression alters angiotensin I-converting enzyme gene expression in vessels and epithelia.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Gene Expression Regulation, Enzymologic; Guinea Pigs; Humans; Losartan; Male; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Renin; RNA, Messenger | 1998 |
Effects of combination therapy with enalapril and losartan on the rate of progression of renal injury in rats with 5/6 renal mass ablation.
Topics: Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Drug Therapy, Combination; Enalapril; Glomerulonephritis; Kidney; Kidney Diseases; Linear Models; Losartan; Male; Nephrectomy; Organ Size; Proteinuria; Rats; Rats, Wistar | 1998 |
High-protein diets augment albuminuria in rats with Heymann nephritis by angiotensin II-dependent and -independent mechanisms.
Topics: Albuminuria; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Dietary Proteins; Enalapril; Glomerular Filtration Rate; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin | 1998 |
Protection of the arterial internal elastic lamina by inhibition of the renin-angiotensin system in the rat.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Aorta, Abdominal; Aorta, Thoracic; Aortic Rupture; Benzimidazoles; Blood Pressure; Body Weight; Calcium Channel Blockers; Collagen; Elastic Tissue; Elastin; Enalapril; Heart; Heart Rate; Losartan; Male; Mibefradil; Muscle, Smooth, Vascular; Organ Size; Peptidyl-Dipeptidase A; Rats; Rats, Inbred BN; Renin; Renin-Angiotensin System; Tetrahydronaphthalenes | 1998 |
I'm a 57-year-old man with high blood pressure and high cholesterol. I had a hard time regulating my pressure until I went on Vasotec, which was great. But I developed a cough, so my doctor switched me to Cozaar. My cough stopped and my pressure seems oka
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Humans; Hypercholesterolemia; Hypertension; Losartan; Male; Middle Aged | 1998 |
Divergent effects of angiotensin-converting enzyme inhibition and angiotensin II-receptor antagonism on myocardial cellular proliferation and collagen deposition after myocardial infarction in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cell Division; Collagen; Enalapril; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley | 1998 |
Angiotensin II receptor antagonists: what future?
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Antihypertensive Agents; Enalapril; Humans; Hypertension; Losartan | 1998 |
Effects of losartan and enalapril on small artery structure in hypertensive rats.
Topics: Animals; Antihypertensive Agents; Arteries; Blood Pressure; Cell Division; Dose-Response Relationship, Drug; Enalapril; Heart Ventricles; Hypertension; Losartan; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1998 |
Interaction of mRNAs for angiotensin II type 1 and type 2 receptors to vascular remodeling in spontaneously hypertensive rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Collagen; Enalapril; Gene Expression; Imidazoles; Losartan; Male; Muscle, Smooth, Vascular; Peptidyl-Dipeptidase A; Pyridines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Angiotensin; RNA, Messenger | 1998 |
Contrasting renal effects of chronic administrations of enalapril and losartan on one-kidney, one clip hypertensive rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Diet, Sodium-Restricted; Enalapril; Glomerular Filtration Rate; Hypertension, Renovascular; Kidney; Kinins; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Sodium | 1998 |
The evolving role of angiotensin-II receptor blockers in cardiovascular risk reduction. Case study.
Topics: Acrylates; Adult; Antihypertensive Agents; Black People; Enalapril; Female; Humans; Hypertension; Imidazoles; Losartan; Receptors, Angiotensin; Thiophenes | 1998 |
Targeting TGF-beta overexpression in renal disease: maximizing the antifibrotic action of angiotensin II blockade.
Topics: Angiotensin II; Animals; Blood Pressure; Body Weight; Eating; Enalapril; Fibronectins; Fibrosis; Glomerulonephritis, Membranoproliferative; Kidney; Losartan; Male; Plasminogen Activator Inhibitor 1; Rats; Rats, Sprague-Dawley; Transforming Growth Factor beta | 1998 |
Renal afferent arteriolar structure in the genetically hypertensive (GH) rat and the ability of losartan and enalapril to cause structural remodelling.
Topics: Animals; Antihypertensive Agents; Arterioles; Blood Pressure; Enalapril; Heart Ventricles; Hypertension; Kidney; Losartan; Rats; Renal Circulation; Vascular Resistance | 1998 |
Cough and angiotensin II receptor antagonists: cause or confounding?
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Cohort Studies; Confounding Factors, Epidemiologic; Cough; Data Collection; Drug Monitoring; Enalapril; Female; Humans; Indoles; Lisinopril; Losartan; Male; Middle Aged; Perindopril | 1999 |
Losartan and enalapril therapies enhance vasodilatation in the mesenteric artery of spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Diclofenac; Enalapril; Endothelium; Enzyme Inhibitors; Heart Rate; Hypertension; In Vitro Techniques; Losartan; Male; Mesenteric Arteries; Muscle Contraction; Muscle Relaxation; NG-Nitroarginine Methyl Ester; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Vasoconstrictor Agents; Vasodilation | 1999 |
The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Division; DNA Replication; Enalapril; Endometrium; Estradiol; Female; Losartan; Ovariectomy; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 1999 |
[Effect of renitek--an ACE inhibitor--versus cozaar--an angiotensin I receptors antagonists--on morphofunctional state of left ventricular myocardium in patients with symptomatic cardiac insufficiency].
Topics: Adult; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Echocardiography; Enalapril; Heart Failure; Heart Ventricles; Humans; Losartan; Middle Aged; Myocardial Contraction; Treatment Outcome | 1999 |
Effects of antihypertensive treatment on cardiac IGF-1 during prevention of ventricular hypertrophy in the rat.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Enalapril; Heart; Hypertrophy, Left Ventricular; Insulin-Like Growth Factor I; Losartan; Male; Methyldopa; Myocardium; Propranolol; Radioimmunoassay; Rats; Rats, Sprague-Dawley | 1999 |
Apoptosis during regression of cardiac hypertrophy in spontaneously hypertensive rats. Temporal regulation and spatial heterogeneity.
Topics: Adrenergic beta-Antagonists; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Apoptosis; Calcium Channel Blockers; Cardiomegaly; Data Interpretation, Statistical; DNA; DNA Fragmentation; Enalapril; Hemodynamics; Hydralazine; Losartan; Male; Nifedipine; Propranolol; Rats; Time Factors | 1999 |
Insulin resistance in adipocytes from spontaneously hypertensive rats: effect of long-term treatment with enalapril and losartan.
Topics: Adipocytes; Animals; Antihypertensive Agents; Biological Transport; Enalapril; Glucose; Hypertension; Insulin Resistance; Losartan; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 1999 |
Targeting TGF-beta overexpression: maximizing the antifibrotic actions of angiotensin II blockade in anti-Thy1 glomerulonephritis.
Topics: Angiotensin II; Animals; Enalapril; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Thy-1 Antigens; Transforming Growth Factor beta | 1999 |
Differing effects of enalapril and losartan on renal medullary blood flow and renal interstitial hydrostatic pressure in spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Enalapril; Hydrostatic Pressure; Kidney Medulla; Laser-Doppler Flowmetry; Losartan; Male; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renal Circulation | 1999 |
[Effect of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome].
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Doxorubicin; Eicosanoids; Enalapril; F2-Isoprostanes; Losartan; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar | 1999 |
Differential regulation of cardiac adrenomedullin and natriuretic peptide gene expression by AT1 receptor antagonism and ACE inhibition in normotensive and hypertensive rats.
Topics: Adrenomedullin; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Atrial Natriuretic Factor; Blood Pressure; Cardiomegaly; Enalapril; Gene Expression; Heart; Hypertension; Losartan; Male; Natriuretic Peptide, Brain; Peptides; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Reference Values | 1999 |
Enalapril and losartan augment endogenous nitric oxide release in Takayasu's arteritis--a case report.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Endothelin-1; Female; Humans; Hypertension, Renovascular; Losartan; Middle Aged; Nephrectomy; Nitric Oxide; Prognosis; Renal Artery Obstruction; Takayasu Arteritis; Vasoconstrictor Agents; Vasodilator Agents | 2000 |
Paracrine effects of angiotensin-converting-enzyme- and angiotensin-II-receptor- inhibition on transcapillary glucose transport in humans.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Biological Transport; Bradykinin; Capillaries; Enalapril; Glucose; Humans; Hyperinsulinism; Losartan; Male; Receptors, Angiotensin | 2000 |
Differential effects of short-term ace- and AT1-receptor inhibition on postischemic injury and leukocyte adherence in vivo and in vitro.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Capillaries; Cell Adhesion; Cell Death; Cell Hypoxia; Cell Line; Cricetinae; Enalapril; Endothelium, Vascular; Hemodynamics; Hemorheology; Humans; Interleukin-1; Leukocytes; Losartan; Mesocricetus; Neutrophils; Peptidyl-Dipeptidase A; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Reperfusion Injury | 2000 |
Arterial responses in vitro and plasma digoxin immunoreactivity after losartan and enalapril treatments in experimental hypertension.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Cardiomegaly; Digoxin; Dihydropyridines; Enalapril; Heart; Hypertension; Losartan; Male; Mesenteric Arteries; Muscle, Smooth, Vascular; Nifedipine; Organ Size; Potassium Chloride; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Sodium-Potassium-Exchanging ATPase; Tunica Media | 2000 |
Angiotensin II blockade and low-protein diet produce additive therapeutic effects in experimental glomerulonephritis.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Diet, Protein-Restricted; Enalapril; Glomerulonephritis; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Transforming Growth Factor beta; Treatment Outcome | 2000 |
Mechanism of reduced GFR in rabbits with ischemic acute renal failure.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Biomarkers; Creatinine; Enalapril; Female; Glomerular Filtration Rate; Ischemia; Kidney; Kidney Tubules; Losartan; Male; Rabbits; Renal Circulation; Urodynamics | 2000 |
Proapoptotic and growth-inhibitory role of angiotensin II type 2 receptor in vascular smooth muscle cells of spontaneously hypertensive rats in vivo.
Topics: Angiotensin II; Animals; Antihypertensive Agents; Apoptosis; Cell Division; Enalapril; Hypertension; Losartan; Muscle, Smooth, Vascular; Rats; Rats, Inbred SHR; Receptors, Angiotensin | 2000 |
Role of patient factors in therapy resistance to antiproteinuric intervention in nondiabetic and diabetic nephropathy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Inflammatory Agents, Non-Steroidal; Diabetic Nephropathies; Enalapril; Humans; Indomethacin; Kidney Diseases; Lisinopril; Losartan; Proteinuria | 2000 |
Endothelin-1 attenuates bradykinin-induced hypotension in rats.
Topics: Administration, Oral; Animals; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Enalapril; Endothelin-1; Hypotension; Injections, Intravenous; Losartan; Male; Rats; Rats, Wistar | 2000 |
Regional renal haemodynamics of angiotensin II infusion under prostaglandin, kinin or converting enzyme inhibition in the Wistar rat.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aprotinin; Bradykinin; Enalapril; Hemodynamics; Ketoprofen; Kidney Medulla; Losartan; Male; Nitric Oxide; Prostaglandin Antagonists; Rats; Rats, Wistar; Renal Circulation | 2000 |
Contribution of angiotensin II to late renal injury after acute ischemia.
Topics: Acute Disease; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Progression; Enalapril; Ischemia; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Renal Circulation; Time Factors | 2000 |
Effects of acute angiotensin II type 1 receptor antagonism and angiotensin converting enzyme inhibition on plasma fibrinolytic parameters in patients with heart failure.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Circadian Rhythm; Drug Interactions; Enalapril; Fibrinolysis; Heart Failure; Humans; Losartan; Randomized Controlled Trials as Topic; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin-Angiotensin System | 2000 |
[Erythrocytosis post kidney transplantation and its pharmacological treatment: angiotensin converting enzyme inhibitors or angiotensin receptor blockers in a case].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Enalapril; Humans; Kidney Transplantation; Losartan; Male; Peptidyl-Dipeptidase A; Polycythemia | 2000 |
Renin-angiotensin system inhibitors as antihypertrophic agents.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kidney; Kidney Diseases; Losartan; Nephrectomy; Ramipril; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2000 |
Interaction between AT1 and alpha1-adrenergic receptors in cardiomyopathic hamsters.
Topics: Angiotensin I; Animals; Antihypertensive Agents; Aorta; Cardiomyopathies; Cricetinae; Disease Models, Animal; Enalapril; Humans; Losartan; Male; Mesocricetus; Muscle Contraction; Muscle, Smooth, Vascular; Prazosin; Receptor Cross-Talk; Receptors, Adrenergic, alpha-1; Receptors, Angiotensin; Vascular Resistance | 2000 |
Effect of angiotensin II blockade on renal injury in mineralocorticoid-salt hypertension.
Topics: Administration, Oral; Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Disease Models, Animal; Enalapril; Hypertension, Renal; Kidney; Kidney Function Tests; Losartan; Male; Nephrectomy; Proteinuria; Rats; Rats, Wistar; Renal Insufficiency; Sodium Chloride | 2000 |
Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy.
Topics: Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Collagen; Echocardiography, Doppler; Enalapril; Enzyme-Linked Immunosorbent Assay; Extracellular Matrix; Humans; Hypertension; Hypertrophy, Left Ventricular; Losartan; Male; Matrix Metalloproteinase 9; Middle Aged; Time Factors; Tissue Inhibitor of Metalloproteinase-1; Ventricular Function, Left | 2000 |
New approach in the therapy of chronic rejection? ACE- and AT1-blocker reduce the development of chronic rejection after cardiac transplantation in a rat model.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Coronary Vessels; Cyclosporine; Enalapril; Graft Rejection; Graft Survival; Heart Transplantation; Immunosuppressive Agents; Losartan; Male; Premedication; Rats; Rats, Inbred F344; Rats, Inbred Lew; Transplantation, Heterotopic | 2000 |
Beneficial effect of combination therapy with an angiotensin II receptor antagonist and angiotensin-converting enzyme inhibitor on overt proteinuria in a patient with type 1 diabetic nephropathy.
Topics: Adult; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Calcium Channel Blockers; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Proteinuria | 2000 |
Effect of chronic angiotensin II inhibition on the cardiovascular system of the normal rat.
Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Body Weight; Cardiovascular System; Collagen; Cyclic GMP; DNA; Drinking; Enalapril; Fibrosis; Losartan; Male; Myocardium; NADPH Dehydrogenase; Rats; Rats, Wistar; Reference Values; Systole; Time Factors | 2000 |
Losartan versus enalapril on cerebral edema and proteinuria in stroke-prone hypertensive rats.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Brain Edema; Drug Administration Schedule; Enalapril; Genetic Predisposition to Disease; Hypertension; Losartan; Male; Proteinuria; Rats; Rats, Inbred SHR; Stroke; Survival Analysis | 2001 |
Acute effects of E-3174, a human active metabolite of losartan, on the cardiovascular system in tachycardia-induced canine heart failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cardiovascular System; Dogs; Echocardiography; Electric Stimulation; Enalapril; Heart Failure; Hemodynamics; Hormones; Imidazoles; Losartan; Male; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Renin-Angiotensin System; Tachycardia; Tetrazoles; Ventricular Function | 2001 |
Modulation of alveolar-capillary sodium handling as a mechanism of protection of gas transfer by enalapril, and not by losartan, in chronic heart failure.
Topics: Adult; Aged; Capillary Permeability; Enalapril; Heart Failure; Hemodynamics; Humans; Losartan; Male; Middle Aged; Pulmonary Alveoli; Pulmonary Diffusing Capacity; Pulmonary Gas Exchange; Sodium; Sodium Channels; Up-Regulation | 2001 |
Acute administration of nicotine impairs the hypotensive responses to bradykinin in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Bradykinin; Dose-Response Relationship, Drug; Enalapril; Endothelium, Vascular; Ganglionic Stimulants; Hypotension; Losartan; Male; Nicotine; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2 | 2001 |
Plasma levels of vascular endothelial growth factor and its soluble receptor (SFlt-1) in essential hypertension.
Topics: Antihypertensive Agents; Enalapril; Endothelial Growth Factors; Enzyme-Linked Immunosorbent Assay; Female; Humans; Losartan; Lymphokines; Male; Middle Aged; Pilot Projects; Prospective Studies; Proto-Oncogene Proteins; Receptor Protein-Tyrosine Kinases; Receptors, Growth Factor; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factors | 2001 |
Modulation of the renin-angiotensin system may alter the adrenocortical regeneration.
Topics: Adrenal Cortex; Adrenalectomy; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Calcium Channel Blockers; Cell Division; Enalapril; Losartan; Male; Mitosis; Nifedipine; Rats; Rats, Wistar; Regeneration; Renin; Renin-Angiotensin System; Steroids | 2001 |
Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Cardiomegaly; Enalapril; Furosemide; Guanylate Cyclase; Hydralazine; Losartan; Mice; Mice, Inbred C57BL; Mice, Knockout; Mitogen-Activated Protein Kinases; Myocardium; Organ Size; Propranolol; Receptors, Atrial Natriuretic Factor; Telemetry; Ventricular Dysfunction, Left | 2001 |
The influence of chronic antihypertensive treatment on the central pressor response in SHR.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Body Weight; Brain; Enalapril; Epinephrine; Heart Rate; Hydralazine; Hydrochlorothiazide; Hypertension; Injections, Intraventricular; Losartan; Male; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Saline Solution, Hypertonic; Tetrazoles | 2001 |
Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Blood Pressure; Captopril; Enalapril; Lisinopril; Losartan; Male; Pancreatic Elastase; Rats; Rats, Wistar | 2001 |
Remission achieved in chronic nephropathy by a multidrug approach targeted at urinary protein excretion.
Topics: Adult; Algorithms; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diuretics; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Kidney Diseases; Kidney Failure, Chronic; Losartan; Lupus Nephritis; Proteinuria; Sodium Chloride Symporter Inhibitors | 2001 |
IgA nephropathy and inhibitors of the renin angiotensin system: is reduction in proteinuria adequate proof of efficacy?
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Drug Synergism; Drug Therapy, Combination; Enalapril; Glomerulonephritis, IGA; Humans; Losartan; Proteinuria; Renin; Treatment Outcome | 2001 |
Effect of chronic angiotensin II inhibition on the nitric oxide synthase in the normal rat during aging.
Topics: Aging; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aorta; Blood Pressure; Cardiomegaly; Enalapril; Losartan; Male; NADPH Dehydrogenase; Nitrates; Nitric Oxide Synthase; Nitrites; Rats; Rats, Wistar; Reference Values; Time Factors | 2001 |
Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats.
Topics: 6-Ketoprostaglandin F1 alpha; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Bone Density; Dinoprost; Dinoprostone; Enalapril; F2-Isoprostanes; Female; Femur; Losartan; Proteinuria; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Thromboxane B2 | 2001 |
Differential subcellular actions of ACE inhibitors and AT(1) receptor antagonists on cardiac remodeling induced by chronic inhibition of NO synthesis in rats.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Cardiomegaly; Coronary Vessels; Enalapril; Enzyme Inhibitors; Heart Rate; Heart Ventricles; Imidazoles; Losartan; Male; Mitogen-Activated Protein Kinases; Myocardium; Neutrophil Infiltration; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Olmesartan Medoxomil; Organ Size; Rats; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Ribosomal Protein S6 Kinases; Tetrazoles; Thiazepines | 2001 |
[In contrast to captopril and enalapril, losartan does not increase mortality of gerbils after carotid ligation].
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Cardiovascular Surgical Procedures; Carotid Arteries; Disease Models, Animal; Enalapril; Gerbillinae; Ligation; Losartan; Myocardial Ischemia; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Survival Analysis | 2001 |
Renal protective effects of chronic exercise and antihypertensive therapy in hypertensive rats with chronic renal failure.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Enalapril; Hypertension; Kidney; Kidney Failure, Chronic; Losartan; Male; Motor Activity; Proteinuria; Rats; Rats, Inbred SHR; Time Factors | 2001 |
Drug companies should not have the final say in the design of clinical trials.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biphenyl Compounds; Clinical Trials as Topic; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Industry; Enalapril; Humans; Irbesartan; Losartan; Research Design; Tetrazoles | 2001 |
Combined use of enalapril and losartan to reduce proteinuria: a question of safety.
Topics: Adolescent; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Drug Therapy, Combination; Enalapril; Humans; Hyperkalemia; Losartan; Proteinuria; Receptor, Angiotensin, Type 1 | 2002 |
The expression of AT1 receptor on hepatic stellate cells in rat fibrosis induced by CCl4.
Topics: Alanine Transaminase; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Cells, Cultured; Enalapril; Fibrosis; Immunohistochemistry; Liver; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System | 2001 |
Effects of long-term enalapril and losartan therapy of hypertension on cardiovascular aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Cardiovascular System; Drug Administration Schedule; Enalapril; Hypertension; Losartan; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Rats, Wistar; Receptor, Angiotensin, Type 1; Reference Values | 2001 |
Effects of antihypertensive therapy on intrarenal angiotensin and bradykinin levels in experimental renal insufficiency.
Topics: Aldosterone; Angiotensin II; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Bradykinin; Creatinine; Enalapril; Kidney; Losartan; Male; Nephrectomy; Nifedipine; Proteinuria; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Vasodilator Agents | 2002 |
Influence of losartan and enalapril on urinary excretion of 8-isoprostane in experimental nephrotic syndrome.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Dinoprost; Enalapril; F2-Isoprostanes; Losartan; Nephrotic Syndrome; Rats | 2002 |
Effects of losartan or enalapril on hemoglobin, circulating erythropoietin, and insulin-like growth factor-1 in patients with and without posttransplant erythrocytosis.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Erythropoietin; Female; Hemoglobins; Humans; Insulin-Like Growth Factor I; Kidney Transplantation; Losartan; Male; Middle Aged; Polycythemia | 2002 |
Non-AT(1)-receptor-mediated protective effect of angiotensin against acute ischaemic stroke in the gerbil.
Topics: Acute Disease; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Benzimidazoles; Biphenyl Compounds; Brain Ischemia; Disease Models, Animal; Enalapril; Gerbillinae; Lisinopril; Losartan; Male; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Reproducibility of Results; Stroke; Tetrazoles | 2001 |
Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
Topics: Administration, Oral; Allopurinol; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arterioles; Benzofurans; Blood Pressure; Diuretics; Enalapril; Hydrochlorothiazide; Hypertension; Kidney; Losartan; Male; Muscle, Smooth, Vascular; Oxonic Acid; Rats; Rats, Sprague-Dawley; Sodium Chloride Symporter Inhibitors; Sodium Chloride, Dietary; Uric Acid; Uricosuric Agents; Vascular Diseases | 2002 |
A comparative evaluation of therapeutic effects of once a day dose of losartan potassium versus enalapril maleate in mild to moderate essential hypertension.
Topics: Adult; Antihypertensive Agents; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome | 2001 |
Effects of long-term enalapril and losartan therapy of heart failure on cardiovascular aldosterone.
Topics: Aldosterone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Cardiac Output, Low; Cardiomegaly; Cardiovascular System; Chronic Disease; Enalapril; Losartan; Male; Mesenteric Arteries; Myocardial Infarction; Rats; Rats, Wistar | 2002 |
Effects of antihypertensive therapy on cardiac sodium/hydrogen ion exchanger activity and hypertrophy in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Cardiomegaly; Disease Models, Animal; Enalapril; Hypertension; Losartan; Male; Myocardium; Nifedipine; Rats; Rats, Wistar; Sodium-Hydrogen Exchangers | 2002 |
Angiotensin II regulation of vascular endothelial growth factor and receptors Flt-1 and KDR/Flk-1 in cyclosporine nephrotoxicity.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Cyclosporine; Disease Models, Animal; Enalapril; Endothelial Growth Factors; Extracellular Matrix Proteins; Gene Expression; Immunosuppressive Agents; Intercellular Signaling Peptides and Proteins; Kidney Diseases; Losartan; Lymphokines; Male; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-1; Vascular Endothelial Growth Factor Receptor-2; Vascular Endothelial Growth Factors | 2002 |
Angiotensin II type 1 receptor blockade after cardiac transplantation reduced the incidence and severity of transplant vasculopathy in an animal-based study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Coronary Disease; Enalapril; Heart Transplantation; Losartan; Models, Animal; Postoperative Complications; Rats; Rats, Inbred F344; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Vascular Diseases | 2002 |
Angiotensin II receptor blocker-associated angioedema: on the heels of ACE inhibitor angioedema.
Topics: Adult; Angioedema; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Cough; Diabetes Mellitus, Type 1; Enalapril; Female; Humans; Losartan; Pharyngitis | 2002 |
Different contribution of apoptosis to the antiproliferative effects of L-arginine, enalapril and losartan on neointimal growth inhibition after balloon arterial injury.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Arginine; Carotid Artery Injuries; Catheterization; Cell Division; Enalapril; Graft Occlusion, Vascular; Losartan; Male; Muscle, Smooth, Vascular; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Rats; Rats, Sprague-Dawley; Up-Regulation | 2002 |
Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects.
Topics: Adult; Angiotensin Receptor Antagonists; Antihypertensive Agents; Enalapril; Humans; Hypoxanthine; Losartan; Male; Oxypurinol; Uric Acid; Xanthine | 2002 |
Differential effects of antihypertensive drug therapy on arterial compliance.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Blood Pressure; Calcium Channel Blockers; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Treatment Outcome; Vascular Resistance | 2002 |
Long-term angiotensin II inhibition increases mitochondrial nitric oxide synthase and not antioxidant enzyme activities in rat heart.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Catalase; Enalapril; Glutathione Peroxidase; Hydrogen Peroxide; Losartan; Male; Mitochondria, Heart; Myocardium; Nitric Oxide; Nitric Oxide Synthase; Oxidoreductases; Rats; Rats, Wistar; Superoxide Dismutase; Time Factors | 2002 |
Effect of blockade of endogenous angiotensin II on baroreflex function in conscious diabetic rats.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Baroreflex; Blood Pressure; Consciousness; Diabetes Mellitus, Experimental; Enalapril; Heart Rate; Kidney; Losartan; Male; Rats; Rats, Sprague-Dawley; Sympathetic Nervous System | 2003 |
The effects of losartan and enalapril therapies on the levels of nitric oxide, malondialdehyde, and glutathione in patients with essential hypertension.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Enalapril; Female; Glutathione; Humans; Hypertension; Losartan; Male; Malondialdehyde; Middle Aged; Nitric Oxide; Receptor, Angiotensin, Type 1 | 2002 |
Effects of angiotensin II receptor blockade versus angiotensin-converting-enzyme inhibition on ventricular remodelling following myocardial infarction in the mouse.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Collagen; Enalapril; Gene Expression Regulation; Hemodynamics; Losartan; Male; Mice; Mice, Inbred C57BL; Myocardial Infarction; Receptors, Angiotensin; Reverse Transcriptase Polymerase Chain Reaction; Ultrasonography; Ventricular Remodeling | 2003 |
ST-segment resolution and late (6-month) left ventricular remodeling after acute myocardial infarction.
Topics: Aged; Antihypertensive Agents; Coronary Circulation; Electrocardiography; Enalapril; Female; Humans; Losartan; Male; Microcirculation; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Predictive Value of Tests; Prognosis; Prospective Studies; Radionuclide Ventriculography; Severity of Illness Index; Single-Blind Method; Stroke Volume; Time Factors; Treatment Outcome; Ventricular Remodeling | 2003 |
Persistent lowering of arterial pressure after continuous and intermittent therapy.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Drug Therapy, Combination; Enalapril; Heart Rate; Heart Ventricles; Hydralazine; Hydrochlorothiazide; Hypertension; Losartan; Male; Nifedipine; Rats; Rats, Inbred SHR; Renin-Angiotensin System; Vasodilator Agents | 2003 |
Enalapril and losartan attenuate mitochondrial dysfunction in aged rats.
Topics: Aging; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Respiration; Enalapril; Epithelial Cells; Glutathione; Kidney; Kidney Tubules, Proximal; Losartan; Male; Mitochondria; Models, Biological; Oxidation-Reduction; Rats; Rats, Wistar | 2003 |
Differential anxiolytic effect of enalapril and losartan in normotensive and renal hypertensive rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Anxiety Agents; Antihypertensive Agents; Anxiety; Blood Pressure; Diazepam; Enalapril; Exploratory Behavior; Hypertension, Renal; Losartan; Male; Rats; Rats, Wistar; Social Behavior | 2003 |
Further studies on the effect of intracellular angiotensins on heart cell communication: on the role of endogenous angiotensin II.
Topics: Angiotensin II; Animals; Cell Communication; Cricetinae; Dose-Response Relationship, Drug; Enalapril; Enalaprilat; Losartan; Male; Mesocricetus; Myocardium; Patch-Clamp Techniques; Peptides; Peptidyl-Dipeptidase A; Receptors, Angiotensin; Renin-Angiotensin System; Temperature; Time Factors | 2003 |
Comparison of the effects of losartan, enalapril and their combination in the prevention of left ventricular remodeling after acute myocardial infarction in the rat.
Topics: Animals; Antihypertensive Agents; Drug Synergism; Enalapril; Female; Losartan; Myocardial Infarction; Random Allocation; Rats; Rats, Sprague-Dawley; Ventricular Function, Left; Ventricular Remodeling | 2002 |
Brain nitric oxide synthase activity in spontaneously hypertensive rats during the development of hypertension.
Topics: Age Factors; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Brain; Enalapril; Hydralazine; Hypertension; Losartan; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptor, Angiotensin, Type 1; Vasodilator Agents | 2003 |
Angiotensin II dependent testicular fibrosis and effects on spermatogenesis after vasectomy in the rat.
Topics: Acetylcysteine; Aldehydes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antioxidants; Enalapril; Fibrosis; Heat-Shock Proteins; HSP47 Heat-Shock Proteins; Leydig Cells; Losartan; Male; Rats; Rats, Wistar; Spermatogenesis; Testis; Transforming Growth Factor beta; Transforming Growth Factor beta1; Vasectomy | 2003 |
Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Collagen; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Heart; Heart Ventricles; Kidney; Losartan; Matrix Metalloproteinases; Organ Size; Rats; Rats, Inbred SHR; Rats, Inbred WKY | 2003 |
Renal vascular responsiveness to angiotensin II at an early stage of diabetes: interaction between intrarenal noradrenergic and renin-angiotensin systems.
Topics: Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Enalapril; Losartan; Norepinephrine; Rats; Rats, Wistar; Renin-Angiotensin System; Time Factors; Vasoconstriction | 2003 |
Partial prevention of changes in SR gene expression in congestive heart failure due to myocardial infarction by enalapril or losartan.
Topics: Administration, Oral; Animals; Antihypertensive Agents; Blotting, Northern; Blotting, Western; Calcium; Calcium-Binding Proteins; Calcium-Transporting ATPases; Calsequestrin; Cicatrix; Enalapril; Gene Expression Regulation; Heart Failure; Heart Ventricles; Losartan; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Time Factors | 2003 |
[Prognostic value of elevation of plasma concentration of atrial natriuretic peptide in patients with cardiac failure. Results of a cohort study].
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Antihypertensive Agents; Atrial Natriuretic Factor; Drug Therapy, Combination; Echocardiography, Doppler; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Prognosis; Radioimmunoassay; Regression Analysis; Risk; Time Factors | 2003 |
Haemodynamic effects of dual blockade of the renin-angiotensin system in spontaneously hypertensive rats: influence of salt.
Topics: Anesthesia; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Consciousness; Drug Therapy, Combination; Enalapril; Hypertension, Renal; Kidney; Losartan; Male; Rats; Rats, Inbred SHR; Renal Circulation; Renin-Angiotensin System; Sodium Chloride, Dietary | 2004 |
Losartan ameliorates progression of glomerular structural changes in diabetic KKAy mice.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Kidney; Kidney Glomerulus; Losartan; Male; Mice; Mice, Inbred Strains; Mice, Obese; Organ Size; Receptor, Angiotensin, Type 1; Water Supply | 2004 |
Intrarenal Renin-Angiotensin system is upregulated in experimental model of progressive renal disease induced by chronic inhibition of nitric oxide synthesis.
Topics: Albumins; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Western; Cathepsin D; Enalapril; Enzyme Inhibitors; Glomerulonephritis; Immunohistochemistry; Kidney; Kidney Diseases; Losartan; Male; Mycophenolic Acid; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar; Renin; Renin-Angiotensin System; Time Factors; Up-Regulation | 2004 |
Evaluation of a technique of inducing hypertensive renal insufficiency in cats.
Topics: Amlodipine; Analysis of Variance; Animals; Blood Pressure; Blood Pressure Determination; Cat Diseases; Cats; Diltiazem; Enalapril; Heart Rate; Hypertension, Renal; Infarction; Kidney; Ligation; Losartan; Nephrectomy; Renal Insufficiency; Telemetry; Time Factors | 2004 |
Renin-angiotensin blockade attenuates cardiac myofibrillar remodelling in chronic diabetes.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Diabetes Mellitus, Experimental; Enalapril; Gene Expression; Heart Ventricles; Losartan; Male; Myofibrils; Myosin Heavy Chains; Myosins; Rats; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger | 2004 |
Changes in skeletal muscle SR Ca2+ pump in congestive heart failure due to myocardial infarction are prevented by angiotensin II blockade.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Calcium; Calcium-Transporting ATPases; Captopril; Cyclic AMP-Dependent Protein Kinases; Enalapril; Heart Failure; Imidazolidines; Losartan; Male; Muscle, Skeletal; Muscular Atrophy; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Sarcoplasmic Reticulum; Time Factors | 2004 |
Modification of myosin protein and gene expression in failing hearts due to myocardial infarction by enalapril or losartan.
Topics: Adenosine Triphosphatases; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blotting, Northern; Calcium; Diastole; Enalapril; Gene Expression Regulation; Immunoblotting; Losartan; Magnesium; Male; Myocardial Infarction; Myocardium; Myosin Heavy Chains; Myosins; Protein Isoforms; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Time Factors; Ventricular Function, Left | 2004 |
Changes in beta-adrenoceptors in heart failure due to myocardial infarction are attenuated by blockade of renin-angiotensin system.
Topics: Adenylyl Cyclases; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Heart Failure; Imidazolidines; Isoproterenol; Kinetics; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta; Renin-Angiotensin System; Signal Transduction | 2004 |
Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Drug Synergism; Enalapril; Hypertrophy; Kidney; Losartan; Male; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System; Transforming Growth Factor beta; Transforming Growth Factor beta1 | 2004 |
Sarcoplasmic reticulum Ca2+ transport and gene expression in congestive heart failure are modified by imidapril treatment.
Topics: Animals; Antihypertensive Agents; Calcium; Calcium-Transporting ATPases; Cardiomegaly; Enalapril; Gene Expression; Heart Failure; Imidazolidines; Losartan; Male; Myocardial Infarction; Rats; Rats, Sprague-Dawley; Ryanodine Receptor Calcium Release Channel; Sarcoplasmic Reticulum; Sarcoplasmic Reticulum Calcium-Transporting ATPases; Tritium; Ventricular Pressure | 2005 |
[The additive antiproteinuric effect of Enalapril and Losartan to normotensive patients with pathology proteinuria].
Topics: Adolescent; Antihypertensive Agents; Blood Pressure; Child; Drug Therapy, Combination; Enalapril; Female; Humans; Losartan; Male; Proteinuria | 2004 |
Role of the renin-angiotensin system on the parathyroid hormone-related protein overexpression induced by nephrotoxic acute renal failure in the rat.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Cell Line; Enalapril; Folic Acid; Gentamicins; Kidney; Kidney Tubules; Losartan; Male; Parathyroid Hormone-Related Protein; Quinapril; Rats; Rats, Wistar; Receptor, Parathyroid Hormone, Type 1; Renin-Angiotensin System; Tetrahydroisoquinolines | 2005 |
Effect of losartan and enalapril on cognitive deficit caused by Goldblatt induced hypertension.
Topics: Acetylcholinesterase; Animals; Antihypertensive Agents; Blood Pressure; Brain; Cognition; Enalapril; Humans; Hypertension, Renovascular; Learning; Losartan; Male; Maze Learning; Memory; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Time Factors | 2005 |
Superiority of combination of thiazide with angiotensin-converting enzyme inhibitor or AT1-receptor blocker over thiazide alone on renoprotection in L-NAME/SHR.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Body Weight; Diuretics; Enalapril; Enzyme Inhibitors; Hematocrit; Hemodynamics; Hydrochlorothiazide; Kidney; Kidney Diseases; Kidney Glomerulus; Losartan; Male; NG-Nitroarginine Methyl Ester; Organ Size; Rats; Rats, Inbred SHR; Renal Circulation; Vascular Resistance | 2005 |
Angiotensin-converting enzyme inhibition and angiotensin AT1-receptor antagonism equally improve endothelial vasodilator function in L-NAME-induced hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Bradykinin; Bradykinin Receptor Antagonists; Enalapril; Endothelium, Vascular; Enzyme Inhibitors; Hypertension; In Vitro Techniques; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Nitrites; Norepinephrine; Peptidyl-Dipeptidase A; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Systole; Vasoconstriction; Vasodilation; Vasodilator Agents | 2005 |
Low-affinity state beta1-adrenoceptor-induced vasodilation in SHR.
Topics: Adrenergic beta-1 Receptor Agonists; Alprenolol; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Enalapril; Losartan; Male; Muscle Relaxation; Pindolol; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta-1; Vasodilation | 2005 |
ACE inhibitor and AT1 antagonist stimulate duodenal HCO3- secretion mediated by a common pathway - involvement of PG, NO and bradykinin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Bicarbonates; Blood Pressure; Bradykinin; Dinoprostone; Duodenum; Enalapril; In Vitro Techniques; Losartan; Male; Nitric Oxide; Nitric Oxide Synthase; Prostaglandins; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Signal Transduction | 2005 |
Apoptosis of circulating lymphocyte in rats with unilateral ureteral obstruction: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Enalapril; Leukocyte Count; Losartan; Lymphocytes; Male; Rats; Rats, Wistar; Ureteral Obstruction | 2005 |
R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia.
Topics: Amino Acid Motifs; Amino Acid Sequence; Amino Acid Substitution; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Arginine; Base Sequence; Biopsy; Child; Consanguinity; DNA Helicases; DNA Mutational Analysis; Enalapril; Exons; Follow-Up Studies; Genes, Recessive; Genetic Linkage; Homozygote; Humans; Kidney; Losartan; Male; Molecular Sequence Data; Mutation, Missense; Nephrotic Syndrome; Osteochondrodysplasias; Pedigree; Protein Structure, Tertiary; Radiography; Sequence Homology, Amino Acid; Time Factors; Treatment Outcome; Turkey | 2005 |
Angiotensin II inhibition attenuates postexercise proteinuria in rats.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Kallikrein-Kinin System; Losartan; Male; Physical Conditioning, Animal; Proteinuria; Rats; Rats, Wistar | 2005 |
Impact of antihypertensive treatments on erectile responses in aging spontaneously hypertensive rats.
Topics: Aging; Animals; Antihypertensive Agents; Apomorphine; Blood Pressure; Enalapril; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney Transplantation; Losartan; Male; Nifedipine; Penile Erection; Random Allocation; Rats; Rats, Inbred SHR; Testosterone | 2006 |
Angiotensin inhibition or blockade for the treatment of patients with quiescent lupus nephritis and persistent proteinuria.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Creatinine; Enalapril; Female; Follow-Up Studies; Humans; Losartan; Lupus Nephritis; Male; Proteinuria; Ramipril; Retrospective Studies; Serum Albumin | 2005 |
Differential protein expression in hypertrophic heart with and without hypertension in spontaneously hypertensive rats.
Topics: Age Factors; Aging; Algorithms; Animals; Antihypertensive Agents; Blotting, Western; Cardiomegaly; Databases, Factual; Electrophoresis, Gel, Two-Dimensional; Enalapril; Hypertension; Losartan; Male; Mass Spectrometry; Myocardium; Peptide Mapping; Proteins; Proteomics; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Trypsin | 2006 |
Internal mammary artery smooth muscle cells resist migration and possess high antioxidant capacity.
Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Amides; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Cells, Cultured; Chemotaxis; Coronary Vessels; Enalapril; Farnesyltranstransferase; Free Radical Scavengers; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Intracellular Signaling Peptides and Proteins; Lipoproteins, LDL; Losartan; Mammary Arteries; Metalloporphyrins; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Pravastatin; Protein Serine-Threonine Kinases; Pyridines; Receptors, Oxidized LDL; rho-Associated Kinases | 2006 |
Blockade of the renin-angiotensin system attenuates sarcolemma and sarcoplasmic reticulum remodeling in chronic diabetes.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Enalapril; Losartan; Male; Malondialdehyde; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sarcolemma; Sarcoplasmic Reticulum; Ventricular Dysfunction, Left; Ventricular Function, Left | 2006 |
Enalapril and losartan restored blood pressure and vascular reactivity in intrauterine undernourished rats.
Topics: Animals; Antihypertensive Agents; Arterioles; Blood Glucose; Blood Pressure; Drug Antagonism; Enalapril; Female; Fetal Growth Retardation; Food Deprivation; Insulin; Losartan; Male; Malnutrition; Mesentery; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Wistar; Renin-Angiotensin System; Vasodilation; Vasodilator Agents | 2007 |
Angiotensin blockade as sole treatment for proteinuric kidney disease in children.
Topics: Adolescent; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Benzimidazoles; Biphenyl Compounds; Blood Pressure; Child; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Female; Glomerular Filtration Rate; Humans; Kidney Diseases; Losartan; Male; Proteinuria; Retrospective Studies; Tetrazoles | 2007 |
Inhibition of the renin-angiotensin system abolishes the proatherogenic effect of uremia in apolipoprotein E-deficient mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antibodies, Anti-Idiotypic; Aorta, Thoracic; Aortic Diseases; Apolipoproteins E; Atherosclerosis; Blood Pressure; Disease Models, Animal; Disease Progression; Drosophila Proteins; Enalapril; Follow-Up Studies; Gene Expression; Immunoglobulin G; Immunoglobulin M; Intercellular Adhesion Molecule-1; Lipoproteins, LDL; Losartan; Mice; Nephrectomy; Oxidation-Reduction; Peptidyl-Dipeptidase A; Prognosis; Receptors, Cell Surface; Renin-Angiotensin System; RNA, Messenger; Uremia; Vascular Cell Adhesion Molecule-1 | 2007 |
Hepatic morphological alterations, glycogen content and cytochrome P450 activities in rats treated chronically with N(omega)-nitro-L-arginine methyl ester (L-NAME).
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Chronic Disease; Cytochrome P-450 Enzyme System; Enalapril; Enzyme Activation; Enzyme Inhibitors; Fasting; Glucose; Glycogen; Glycogen Synthase Kinase 3; Hypertension; Hypertrophy; Liver; Liver Cirrhosis; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Peptidyl-Dipeptidase A; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Renin-Angiotensin System | 2007 |
Pulsology reloaded: commentary on similar effects of treatment on central and brachial blood pressure in older hypertensive subjects.
Topics: Aged; Aged, 80 and over; Aging; Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Brachial Artery; Enalapril; Humans; Hydrochlorothiazide; Hypertension; Losartan; Manometry; Perindopril; Ultrasonography, Doppler | 2007 |
Heart failure treatment profile at the beta blockers era.
Topics: Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Middle Aged; Propanolamines; Severity of Illness Index | 2007 |
Protective effect of long-term angiotensin II inhibition.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Blood Pressure; Body Weight; Cardiovascular System; Enalapril; Losartan; Male; Myocardium; Oxidative Stress; Random Allocation; Rats; Rats, Wistar; Renin-Angiotensin System | 2007 |
Comparative interaction of few antihypertensive drugs with cyclosporine-A in rats.
Topics: Acetylcholine; Animals; Antihypertensive Agents; Aorta, Thoracic; Chromatography, High Pressure Liquid; Cyclosporine; Diltiazem; Drug Interactions; Enalapril; Losartan; Male; Olive Oil; Plant Oils; Propranolol; Rats; Rats, Wistar | 2007 |
Effects of angiotensin II blockade on the development of autoimmune thyroiditis in nonobese diabetic mice.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Hashimoto Disease; Losartan; Mice; Mice, Inbred NOD; Sodium Iodide; Thyroglobulin | 2008 |
Role of the renin angiotensin system in TNF-alpha and Shiga-toxin-induced tissue factor expression.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Cells, Cultured; Dose-Response Relationship, Drug; Drug Combinations; Enalapril; Endothelium, Vascular; Humans; Imidazoles; Kidney Glomerulus; Losartan; Pyridines; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; RNA, Messenger; Shiga Toxin 1; Thromboplastin; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
Delayed effects of hypotensive drugs on structural characteristics of the renal glomerular system in hypertensive NISAG rats.
Topics: Animals; Antihypertensive Agents; Enalapril; Hypertension; Kidney Glomerulus; Losartan; Male; Nifedipine; Prazosin; Rats; Time Factors | 2007 |
Renin-angiotensin system blockade is renoprotective in immune complex-mediated glomerulonephritis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Female; Glomerulonephritis; Losartan; Mice; Renin-Angiotensin System | 2008 |
A one-year study of the antiatherosclerotic effect of the angiotensin-II receptor blocker losartan in hypertensive patients. A comparison with angiotension-converting enzyme inhibitors.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atherosclerosis; Carotid Artery, Common; Enalapril; Humans; Hypertension; Imidazolidines; Losartan; Middle Aged; Tunica Intima; Tunica Media; Ultrasonography | 2008 |
Cough induced by losartan with resolution after substitution with enalapril.
Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Cough; Enalapril; Female; Humans; Hypertension; Losartan | 2008 |
Both enalapril and losartan attenuate sarcolemmal Na+-K+-ATPase remodeling in failing rat heart due to myocardial infarction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Gene Expression Regulation, Enzymologic; Heart Failure; Hemodynamics; Losartan; Male; Myocardial Infarction; Myocardium; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; RNA, Messenger; Sarcolemma; Sodium-Potassium-Exchanging ATPase; Time Factors; Ventricular Dysfunction, Left; Ventricular Remodeling | 2008 |
Effects of antihypertensive drugs on capillary rarefaction in spontaneously hypertensive rats: intravital microscopy and histologic analysis.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Capillaries; Disease Models, Animal; Enalapril; Heart Ventricles; Hypertension; Losartan; Male; Microcirculation; Microscopy, Video; Muscle, Skeletal; Nifedipine; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Skin | 2008 |
Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist combination on nitric oxide bioavailability and atherosclerotic change in Watanabe heritable hyperlipidemic rabbits.
Topics: Acetylcholine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Atherosclerosis; Blood Pressure; Disease Models, Animal; Dose-Response Relationship, Drug; Enalapril; Heart Rate; Hyperlipidemias; Losartan; Male; Nitric Oxide; Peroxynitrous Acid; Rabbits; Tyrosine; Vasodilator Agents | 2008 |
Enalapril and losartan are more effective than carvedilol in preventing dilated cardiomyopathy in the Syrian cardiomyopathic hamster.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carbazoles; Cardiac Output; Cardiomyopathy, Dilated; Carvedilol; Cricetinae; Disease Models, Animal; Disease Progression; Enalapril; Losartan; Male; Mesocricetus; Propanolamines; Renin-Angiotensin System; Stroke Volume; Time Factors; Ultrasonography; Ventricular Function, Left | 2008 |
RAS inhibitors decrease apoptosis of acinar cells and increase elimination of pancreatic stellate cells after in the course of experimental chronic pancreatitis induced by dibutyltin dichloride.
Topics: Actins; Aldosterone; Animals; Apoptosis; Captopril; Cell Proliferation; Enalapril; Immunohistochemistry; Lisinopril; Losartan; Male; Organotin Compounds; Pancreas; Pancreatitis, Chronic; Rats; Rats, Inbred Lew; Renin-Angiotensin System | 2008 |
The relationship between heart rate reserve and oxygen uptake reserve in heart failure patients on optimized and non-optimized beta-blocker therapy.
Topics: Adrenergic beta-Antagonists; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Carbazoles; Carvedilol; Drug Therapy, Combination; Enalapril; Exercise Test; Female; Heart Failure; Heart Rate; Humans; Losartan; Male; Middle Aged; Oxygen Consumption; Propanolamines | 2008 |
Nail-patella syndrome, infantile nephrotic syndrome: complete remission with antiproteinuric treatment.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Enalapril; Female; Humans; Infant; Losartan; Nail-Patella Syndrome; Nephrotic Syndrome; Remission Induction | 2009 |
Beneficial effect of triple treatment plus immunoglobulin in experimental nephrotic syndrome.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Creatinine; Drug Therapy, Combination; Enalapril; Immunoglobulins; Immunologic Factors; Losartan; Male; Nephrotic Syndrome; Proteinuria; Rats; Rats, Wistar; Simvastatin; Time Factors; Treatment Outcome | 2009 |
Cuff-induced vascular intima thickening is influenced by titration of the Ace gene in mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Carotid Arteries; Carotid Artery Injuries; Constriction; Enalapril; Femoral Artery; Gene Dosage; Losartan; Mice; Mice, Transgenic; Peptidyl-Dipeptidase A; Renin-Angiotensin System; Spectrometry, Fluorescence; Tunica Intima | 2009 |
The effect of enalapril on skin flap viability is independent of angiotensin II AT1 receptors.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Graft Survival; Losartan; Male; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Skin; Surgical Flaps; Tissue Survival | 2009 |
Changes seen in the aging kidney and the effect of blocking the renin-angiotensin system.
Topics: Actins; Age Factors; Aging; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Biomarkers; Collagen Type III; Creatinine; Enalapril; Fibrosis; Kidney Glomerulus; Losartan; Male; Proteinuria; Rats; Rats, Wistar; Renin-Angiotensin System; Weaning | 2009 |
Combination effects of enalapril and losartan on lipid peroxidation in the kidneys of KK-Ay/Ta mice.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Drug Synergism; Enalapril; Kidney; Lipid Peroxidation; Losartan; Male; Mice | 2009 |
V1/V2 Vasopressin receptor antagonism potentiates the renoprotection of renin-angiotensin system inhibition in rats with renal mass reduction.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidiuretic Hormone Receptor Antagonists; Benzazepines; Biomarkers; Blood Pressure; Body Weight; Chronic Disease; Disease Models, Animal; Disease Progression; Diuresis; Drinking; Drug Therapy, Combination; Eating; Enalapril; Hormone Antagonists; Kidney; Kidney Diseases; Losartan; Male; Nephrectomy; Proteinuria; Rats; Rats, Sprague-Dawley; Receptors, Vasopressin; Renin-Angiotensin System; Spiro Compounds; Time Factors | 2009 |
Role of the renin-angiotensin system in autoimmune inflammation of the central nervous system.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antigen-Presenting Cells; Cell Movement; Cells, Cultured; Chemokines; Enalapril; Encephalomyelitis, Autoimmune, Experimental; Fumarates; Losartan; Mice; Mice, Inbred C57BL; Myelin Proteins; Myelin-Associated Glycoprotein; Myelin-Oligodendrocyte Glycoprotein; Receptor, Angiotensin, Type 1; Renin; Renin-Angiotensin System | 2009 |
Alterations of cardiac ERK1/2 expression and activity due to volume overload were attenuated by the blockade of RAS.
Topics: Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Abdominal; Cardiomegaly; Drug Therapy, Combination; Enalapril; Heart Failure; Hemodynamics; Losartan; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Random Allocation; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System | 2010 |
Correction of endothelial dysfunction with impaza preparation in complex with enalapril and losartan during modeling of NO deficiency.
Topics: Animals; Antibodies; Enalapril; Hypertension; Losartan; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Wistar | 2009 |
Renin-Angiotensin system blockade for diabetic nephropathy prevention.
Topics: Angiotensin-Converting Enzyme Inhibitors; Benzimidazoles; Biphenyl Compounds; Diabetes Mellitus, Type 1; Diabetic Nephropathies; Enalapril; Female; Humans; Losartan; Male; Prognosis; Randomized Controlled Trials as Topic; Renin-Angiotensin System; Risk Assessment; Tetrazoles; Treatment Outcome | 2010 |
Regulation of the renin expression in the retinal pigment epithelium by systemic stimuli.
Topics: Administration, Oral; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood-Retinal Barrier; Calcium; Cells, Cultured; Enalapril; Epithelial Cells; Infusion Pumps, Implantable; Infusions, Subcutaneous; Kidney; Losartan; Mice; Renin; Renin-Angiotensin System; Retinal Pigment Epithelium; Time Factors; Water Deprivation | 2010 |
Inhibition of the renin-angiotensin system prevents seizures in a rat model of epilepsy.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Blood Pressure; Disease Models, Animal; Drug Evaluation, Preclinical; Enalapril; Epilepsy; Female; Hippocampus; Losartan; Peptidyl-Dipeptidase A; Rats; Rats, Wistar; Receptor, Angiotensin, Type 1; Renin-Angiotensin System | 2010 |
Differential effects of enalapril and losartan on body composition and indices of muscle quality in aged male Fischer 344 × Brown Norway rats.
Topics: Adiposity; Aging; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Body Composition; Body Temperature; Body Weight; Eating; Enalapril; Insulin; Losartan; Magnetic Resonance Spectroscopy; Male; Mitochondria, Muscle; Motor Activity; Muscle Strength; Muscle, Skeletal; Rats; Rats, Inbred F344 | 2011 |
Antiarrhythmic effects of losartan and enalapril in canine pulmonary vein sleeve preparations.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Dose-Response Relationship, Drug; Drug Therapy, Combination; Enalapril; Heart Conduction System; Heart Rate; Losartan; Pulmonary Veins | 2011 |
Pharmacologic inhibition of the renin-angiotensin system did not attenuate hepatic toxicity induced by carbon tetrachloride in rats.
Topics: Alanine Transaminase; Alkaline Phosphatase; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aspartate Aminotransferases; Carbon Tetrachloride; Chemical and Drug Induced Liver Injury; Enalapril; Glutathione; Liver; Losartan; Malondialdehyde; Organ Size; Rats; Rats, Wistar | 2011 |
Inhibition of NF-κB-induced inflammatory responses by angiotensin II antagonists in aged rat kidney.
Topics: Aging; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Gene Expression; Kidney; Losartan; Male; MAP Kinase Signaling System; Nephritis; NF-kappa B; Oxidative Stress; Phosphorylation; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred F344; Transcription Factor RelA | 2011 |
Angiotensin II type 2 receptor signaling attenuates aortic aneurysm in mice through ERK antagonism.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm; Aortic Rupture; Disease Models, Animal; Disease Progression; Enalapril; Losartan; MAP Kinase Signaling System; Marfan Syndrome; Mice; Mice, Knockout; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Receptor, Angiotensin, Type 2; Signal Transduction; Transforming Growth Factor beta | 2011 |
Inhibiting TGF-β activity improves respiratory function in mdx mice.
Topics: Animals; Biomarkers; Body Weight; Cell Adhesion Molecules; Creatine Kinase; Diaphragm; Dose-Response Relationship, Drug; Enalapril; Gene Expression Regulation; Hand Strength; Hydroxyproline; Inflammation; Losartan; Mice; Mice, Inbred mdx; Muscle Fibers, Skeletal; Myogenin; Organ Size; Respiration; Respiratory Function Tests; RNA, Messenger; Transforming Growth Factor beta | 2011 |
Differential effects of late-life initiation of low-dose enalapril and losartan on diastolic function in senescent Fischer 344 x Brown Norway male rats.
Topics: Aging; Analysis of Variance; Animals; Arterial Pressure; Diastole; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Administration Schedule; Echocardiography, Doppler; Enalapril; Heart Function Tests; Heart Rate; Losartan; Male; Myocardial Contraction; Oxidative Stress; Random Allocation; Rats; Rats, Inbred BN; Rats, Inbred F344; Reference Values; Sensitivity and Specificity; Ventricular Function, Left | 2012 |
Comparative effects of different modes of renin angiotensin system inhibition on hypercholesterolaemia-induced atherosclerosis.
Topics: Amides; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Atherosclerosis; Blood Pressure; Cholesterol; Diet, High-Fat; Enalapril; Fumarates; Hypercholesterolemia; Kidney; Losartan; Male; Mice; Mice, Knockout; Receptor, Angiotensin, Type 1; Receptors, LDL; Renin; Renin-Angiotensin System | 2012 |
Co-administration of haloperidol and drugs affecting the angiotensin pathway: effect on the extrapyramidal system.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antipsychotic Agents; Catalepsy; Enalapril; Extrapyramidal Tracts; Haloperidol; Losartan; Male; Mice | 2012 |
Spontaneous remission of post-transplant recurrent focal and segmental glomerulosclerosis.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Disease Progression; Enalapril; Female; Glomerulosclerosis, Focal Segmental; Humans; Kidney Failure, Chronic; Kidney Transplantation; Losartan; Nephrotic Syndrome; Plasmapheresis; Recurrence; Remission, Spontaneous; Treatment Failure | 2011 |
Critical evaluation of the optimal medical therapy in the cardiac resynchronization therapy candidates--single centre experience.
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Carbazoles; Cardiac Resynchronization Therapy; Carvedilol; Defibrillators, Implantable; Enalapril; Female; Heart Failure; Humans; Losartan; Male; Propanolamines | 2011 |
Role of angiotensin and endothelin in testicular ischemia reperfusion injury.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Angiotensins; Animals; Bosentan; Enalapril; Endothelin Receptor Antagonists; Endothelins; Losartan; Male; Malondialdehyde; Rats; Rats, Wistar; Reperfusion Injury; Statistics, Nonparametric; Sulfonamides; Testis | 2012 |
An economic evaluation of antihypertensive therapies based on clinical trials.
Topics: Amlodipine; Antihypertensive Agents; Atenolol; Blood Pressure; Drug Costs; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Randomized Controlled Trials as Topic | 2012 |
Therapeutic resistance to ACEI and ARB combination in macroalbuminuric diabetic nephropathy.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Diabetic Nephropathies; Enalapril; Female; Humans; Losartan; Male; Proteinuria; Social Class | 2012 |
Increased activity of the renin-angiotensin and sympathetic nervous systems is required for regulation of the blood pressure in rats fed a low-protein diet.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Arterial Pressure; Diet, Protein-Restricted; Enalapril; Heart Rate; Losartan; Male; Prazosin; Rats; Rats, Inbred F344; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Sympathetic Nervous System | 2013 |
Structural characteristics of renal glomerular system in ISIAH rats under conditions of chronic stress and preventive hypotensive drug therapy.
Topics: Animals; Antihypertensive Agents; Enalapril; Kidney Glomerulus; Losartan; Male; Prazosin; Rats; Stress, Physiological | 2011 |
Additive antiproteinuric effect of enalapril and losartan in children with hemolytic uremic syndrome.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Child; Child, Preschool; Diarrhea; Drug Therapy, Combination; Enalapril; Female; Hemolytic-Uremic Syndrome; Humans; Infant; Losartan; Male; Proteinuria; Retrospective Studies; Time Factors; Treatment Outcome | 2013 |
Combined treatment with gabapentin and drugs affecting the renin-angiotensin system against electroconvulsions in mice.
Topics: Amines; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Anticonvulsants; Avoidance Learning; Benzimidazoles; Benzoates; Brain; Captopril; Cyclohexanecarboxylic Acids; Drug Therapy, Combination; Electroshock; Enalapril; Gabapentin; gamma-Aminobutyric Acid; Losartan; Male; Mice; Motor Skills; Seizures; Telmisartan | 2013 |
Mineralocorticoid receptor agonists induce mouse aortic aneurysm formation and rupture in the presence of high salt.
Topics: Aldosterone; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta; Aortic Aneurysm, Abdominal; Aortic Aneurysm, Thoracic; Aortic Rupture; Apoptosis; Blood Pressure; Desoxycorticosterone; Disease Models, Animal; Elastin; Enalapril; Eplerenone; Losartan; Male; Mice; Mice, Inbred C57BL; Mineralocorticoid Receptor Antagonists; Muscle, Smooth, Vascular; Oxidative Stress; Receptors, Mineralocorticoid; Sodium Chloride, Dietary; Spironolactone; Time Factors | 2013 |
Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated rat aorta.
Topics: Acetophenones; Acetylcholine; Animals; Aorta; Blood Pressure; Body Weight; Cadmium; Catalase; Densitometry; Enalapril; Endothelium, Vascular; In Vitro Techniques; Losartan; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase Type III; Nitroprusside; Oxidative Stress; Phenylephrine; Rats; Superoxide Dismutase; Systole | 2013 |
Chronic vasodilation increases renal medullary PDE5A and α-ENaC through independent renin-angiotensin-aldosterone system pathways.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cyclic Nucleotide Phosphodiesterases, Type 5; Diuretics; Enalapril; Epithelial Sodium Channels; Female; Kidney Medulla; Losartan; Nephrons; Nifedipine; Pregnancy; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sodium; Sodium Nitrite; Spironolactone; Vasodilation; Vasodilator Agents | 2013 |
Acidosis and hyperkalemia caused by losartan and enalapril in pediatric kidney transplant recipients.
Topics: Acidosis; Adolescent; Age Factors; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Biomarkers; Blood Pressure; Child; Child, Preschool; Drug Therapy, Combination; Enalapril; Female; Humans; Hydrogen-Ion Concentration; Hyperkalemia; Hypertension; Kidney Transplantation; Losartan; Male; Potassium; Proteinuria; Retrospective Studies; Risk Factors; Time Factors; Treatment Outcome | 2014 |
Comparative effects of the renin-angiotensin system blockers on nonalcoholic fatty liver disease and insulin resistance in C57BL/6 mice.
Topics: Adipose Tissue; Amides; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Glucose; Enalapril; Fumarates; Gene Expression Profiling; Gene Expression Regulation; Gluconeogenesis; Insulin Resistance; Leptin; Lipid Metabolism; Losartan; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Renin-Angiotensin System | 2014 |
The effects of enalapril and losartan on mechanical ventilation-induced sympathoadrenal activation and oxidative stress in rats.
Topics: Adrenal Medulla; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Female; Hypothalamus; Losartan; Lung Diseases; Oxidative Stress; Rats; Rats, Sprague-Dawley; Respiration, Artificial; Sympathetic Nervous System | 2014 |
Comparing individual angiotensin-converting enzyme inhibitors with losartan in the risk of hospitalization for pneumonia and related mortality: a nationwide cohort study.
Topics: Aged; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cohort Studies; Enalapril; Female; Hospitalization; Humans; Incidence; Losartan; Male; Middle Aged; Pneumonia; Ramipril; Risk; Taiwan | 2015 |
Profibrosing effect of angiotensin converting enzyme inhibitors in human lung fibroblasts.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Cells, Cultured; Collagen Type I; Collagen Type I, alpha 1 Chain; Enalapril; Fibroblasts; Fibrosis; Fumarates; Humans; Losartan; Lung; Protein Biosynthesis; Renin; Transcription, Genetic; Transforming Growth Factor beta1 | 2015 |
The Effects of the Angiotensin Converting Enzyme Inhibitor Enalapril and the Angiotensin II Type 1 Receptor Blocker Losartan on Fracture Healing in Rats.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Enalapril; Fracture Healing; Losartan; Male; Rats; Rats, Wistar | 2015 |
Losartan and enalapril decrease viral absorption and interleukin 1 beta production by macrophages in an experimental dengue virus infection.
Topics: Animals; Culicidae; Dengue; Dengue Virus; Enalapril; Humans; Interleukin-1beta; Losartan; Macrophages; Male; Mice; Virus Attachment | 2015 |
Angiotensin Receptor Blocker Losartan Inhibits Spontaneous Motility of Isolated Human Ureter.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Carcinoma, Renal Cell; Enalapril; Female; Humans; In Vitro Techniques; Losartan; Male; Middle Aged; Muscle Contraction; Osmolar Concentration; Ureter | 2016 |
AT1 receptor blocker losartan protects against mechanical ventilation-induced diaphragmatic dysfunction.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Diaphragm; Enalapril; Female; Losartan; Muscle Weakness; Rats; Rats, Sprague-Dawley; Respiration, Artificial | 2015 |
Renal oxidative stress and renal CD8(+) T-cell infiltration in mercuric chloride-induced nephropathy in rats: role of angiotensin II.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Catalase; CD8-Positive T-Lymphocytes; Enalapril; Glutathione; Kidney; Kidney Diseases; Losartan; Male; Malondialdehyde; Mercuric Chloride; Necrosis; Oxidative Stress; Rats; Rats, Sprague-Dawley | 2016 |
COMPARISON OF LOSARTAN AND ENALAPRIL EFFECTS ON RENAL FUNCTION IN HYPERTENSIVE ADULTS WITH CHRONIC KIDNEY DISEASE AT A KENYAN REFERRAL HOSPITAL.
Topics: Adult; Aged; Antihypertensive Agents; Creatinine; Diabetic Nephropathies; Enalapril; Female; Humans; Hypertension; Kenya; Kidney Function Tests; Losartan; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Retrospective Studies | 2014 |
Enalapril Alone or Co-Administered with Losartan Rescues Cerebrovascular Dysfunction, but not Mnemonic Deficits or Amyloidosis in a Mouse Model of Alzheimer's Disease.
Topics: Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Amyloidosis; Analysis of Variance; Animals; Antihypertensive Agents; Cerebrovascular Disorders; Cholinesterases; Disease Models, Animal; Drug Combinations; Enalapril; Female; Glial Fibrillary Acidic Protein; Humans; Losartan; Male; Maze Learning; Memory Disorders; Mice; Mice, Transgenic; Mutation | 2016 |
Role of O-linked N-acetylglucosamine modification in diabetic nephropathy.
Topics: Acetylglucosamine; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Blood Pressure; Cell Line; Cell Survival; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Glycosylation; HSP72 Heat-Shock Proteins; Humans; Kidney; Kidney Tubules, Proximal; Losartan; Male; Nitric Oxide Synthase Type III; Phosphorylation; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Rats; Rats, Wistar; Renin-Angiotensin System; Signal Transduction | 2016 |
Renin-Angiotensin-Aldosterone System Inhibition Increases Podocyte Derivation from Cells of Renin Lineage.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Cell Lineage; Cell Movement; Cell Transdifferentiation; Enalapril; Losartan; Male; Mice; Podocytes; Renin; Renin-Angiotensin System | 2016 |
[INTERACTION OF BETA-BLOCKER PROPRANOLOL WITH RENIN-ANGIOTENSIN SYSTEM INHIBITORS IN RAT KIDNEY].
Topics: Amides; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diuresis; Diuretics; Drug Synergism; Enalapril; Fumarates; Kidney; Losartan; Male; Natriuresis; Potassium; Propranolol; Rats; Renin-Angiotensin System; Sodium | 2016 |
Physical training associated with Enalapril but not to Losartan, results in better cardiovascular autonomic effects.
Topics: Animals; Antihypertensive Agents; Atropine; Autonomic Nervous System; Baroreflex; Blood Pressure; Combined Modality Therapy; Disease Models, Animal; Enalapril; Exercise Therapy; Heart Rate; Hypertension; Losartan; Male; Parasympatholytics; Propranolol; Rats, Inbred SHR; Sedentary Behavior; Swimming | 2017 |
Association of obstructive sleep apnea with arterial stiffness and nondipping blood pressure in patients with hypertension.
Topics: Adult; Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brazil; Cardiovascular Diseases; Diuretics; Echocardiography; Enalapril; Female; Humans; Hydrochlorothiazide; Hypertension; Losartan; Male; Middle Aged; Polysomnography; Pulse Wave Analysis; Risk Factors; Sleep Apnea, Obstructive; Vascular Stiffness | 2017 |
Lineage tracing aged mouse kidneys shows lower number of cells of renin lineage and reduced responsiveness to RAAS inhibition.
Topics: Age Factors; Aging; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Apoptosis; Blood Pressure; Cell Lineage; Cell Proliferation; Cellular Senescence; Enalapril; Female; Genes, Reporter; Kidney; Losartan; Luminescent Proteins; Mice, Transgenic; Nephrectomy; Red Fluorescent Protein; Renin; Renin-Angiotensin System | 2018 |
Transforming growth factor-β1 induces cerebrovascular dysfunction and astrogliosis through angiotensin II type 1 receptor-mediated signaling pathways.
Topics: Animals; Brain; Enalapril; Female; Fibrosis; Gliosis; Losartan; Male; Mice; Mice, Transgenic; Receptor, Angiotensin, Type 1; Signal Transduction; Transforming Growth Factor beta1 | 2018 |
Antidepressant-like effect of losartan involves TRKB transactivation from angiotensin receptor type 2 (AGTR2) and recruitment of FYN.
Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Animals; Antidepressive Agents; Captopril; Carbazoles; Cells, Cultured; Cerebral Cortex; Enalapril; Hippocampus; Imidazoles; Immobility Response, Tonic; Indole Alkaloids; Losartan; Male; Mice; Microinjections; Prefrontal Cortex; Proto-Oncogene Proteins c-fyn; Pyridines; Rats; Receptor, Angiotensin, Type 2; Receptor, trkB; Transcriptional Activation | 2018 |
Cytotoxic and genotoxic effects of antihypertensives distributed in Brazil by social programs: Are they safe?
Topics: Antihypertensive Agents; Atenolol; Brazil; Captopril; Cell Survival; Cells, Cultured; DNA Damage; Dose-Response Relationship, Drug; Enalapril; Government Programs; Humans; Hydrochlorothiazide; Hypertension; Losartan; Lymphocytes; Macrophages; Male; Mutagenicity Tests; Program Evaluation; Propranolol | 2018 |
Mast cell population in the development of diabetic nephropathy: Effects of renin angiotensin system inhibition.
Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Enalapril; Fumarates; Glomerular Filtration Rate; Losartan; Male; Mast Cells; Rats; Rats, Wistar; Renin-Angiotensin System | 2018 |
Inhibitors of the renin-angiotensin system ameliorates clinical and pathological aspects of experimentally induced nephrotoxic serum nephritis.
Topics: Albuminuria; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Disease Models, Animal; Enalapril; Glomerular Filtration Rate; Kidney; Losartan; Mice; Nephritis; Renin-Angiotensin System | 2018 |
Effects of enalapril and losartan alone and in combination with sodium valproate on seizures, memory, and cardiac changes in rats.
Topics: Animals; Anticonvulsants; Drug Therapy, Combination; Enalapril; Heart Diseases; Kindling, Neurologic; Losartan; Male; Memory; Pentylenetetrazole; Rats; Rats, Wistar; Seizures; Treatment Outcome; Valproic Acid | 2019 |
Protective effects of tribulus terrestris extract and angiotensin blockers on testis steroidogenesis in copper overloaded rats.
Topics: Angiotensins; Animals; Antihypertensive Agents; Blood Pressure; Copper; Enalapril; Fertility; Losartan; Male; Oxidative Stress; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Spermatogenesis; Testis; Tribulus | 2019 |
[Prescription of renin-angiotensin-aldosterone system blockers in patients with stage 3 chronic kidney disease].
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Angiotensin-Converting Enzyme Inhibitors; Creatinine; Diabetes Mellitus; Disease Progression; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Proteinuria; Renal Insufficiency, Chronic; Renin-Angiotensin System; Treatment Adherence and Compliance | 2019 |
Facts and reflections on COVID-19 and anti-hypertensives drugs.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Betacoronavirus; Coronavirus Infections; COVID-19; Enalapril; Humans; Hypertension; Losartan; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; SARS-CoV-2; Virus Internalization | 2020 |
Effects of Renin-Angiotensin Inhibition on ACE2 (Angiotensin-Converting Enzyme 2) and TMPRSS2 (Transmembrane Protease Serine 2) Expression: Insights Into COVID-19.
Topics: Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme 2; Angiotensin-Converting Enzyme Inhibitors; Animals; Betacoronavirus; Coronavirus Infections; COVID-19; Enalapril; Losartan; Male; Mice; Mice, Inbred C57BL; Pandemics; Peptidyl-Dipeptidase A; Pneumonia, Viral; RNA, Messenger; SARS-CoV-2; Serine Endopeptidases; Tissue Distribution | 2020 |
Soluble angiotensin-converting enzyme levels in heart failure or acute coronary syndrome: revisiting its modulation and prognosis value.
Topics: Acute Coronary Syndrome; ADAM17 Protein; Adrenergic beta-Antagonists; Aged; Aged, 80 and over; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme 2; Enalapril; Female; Heart Failure; Human Umbilical Vein Endothelial Cells; Humans; Kaplan-Meier Estimate; Losartan; Male; Metoprolol; Middle Aged; Peptidyl-Dipeptidase A; Prognosis | 2021 |
The Effect of Enalapril, Losartan, or Not Antihypertensive on the Oxidative Status in Renal Transplant Recipients.
Topics: Antihypertensive Agents; Enalapril; Humans; Kidney; Kidney Transplantation; Losartan; Oxidative Stress | 2022 |
METATYPICAL BCCS OF THE NOSE TREATED SUCCESSFULLY VIA BILOBED TRANSPOSITION FLAP: NITROSAMINES IN ACES (ENALAPRIL), ARBS (LOSARTAN) AS POSSIBLE SKIN CANCER KEY TRIGGERING FACTOR.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Carcinoma, Basal Cell; Enalapril; Humans; Losartan; Nitrosamines; Retrospective Studies; Skin Neoplasms; Sodium Chloride Symporter Inhibitors | 2023 |
NITROSOGENESIS OF SKIN CANCER: THE NITROSAMINE CONTAMINATION IN THE CALCIUM CHANNEL BLOCKERS (AMLODIPINE), BETA BLOCKERS (BISOPROLOL), SARTANS (VALSARTAN/LOSARTAN), ACE INHIBITORS (PERINDOPRIL/ENALAPRIL), TRICYCLIC ANTIDEPRESSANTS (MELITRACEN), SSRIS (PAR
Topics: Amlodipine; Angiotensin II Type 1 Receptor Blockers; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antidepressive Agents, Tricyclic; Bisoprolol; Calcium Channel Blockers; Enalapril; Humans; Incidence; Losartan; Metformin; Paroxetine; Perindopril; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Skin Neoplasms; Valsartan; Venlafaxine Hydrochloride | 2023 |
Comparing Cardiovascular Outcomes and Costs of Perindopril-, Enalapril- or Losartan-Based Antihypertensive Regimens in South Africa: Real-World Medical Claims Database Analysis.
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Enalapril; Humans; Hypertension; Losartan; Perindopril; South Africa | 2023 |